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ABSTRACT
The usage of marijuana has become more accepted in the United States over time.
Thirty states have medical marijuana programs and nine states have legalized
marijuana for recreational use. Politicians and public interest groups have widely
debated the de-criminalization of marijuana use on the federal level. However, as
with legalizing any mind-altering substance, there are issues that need to be
considered. One of these issues is the arrest and prosecution of people driving under
the influence of marijuana. There are several problems with efficient testing for
tetrahydrocannabinol (THC), the primary psychoactive cannabinoid in marijuana.
THC is fat soluble and can be stored in the fatty tissues of the body and released
back into the blood in the days or weeks after consumption. In addition, THC levels
in the blood and bodily excretions do not correlate directly to the level of
intoxication or impairment. Due to these characteristics and others, there is
currently no consistent and accurate way to test for marijuana intoxication. This
paper will examine several of the tests that are currently used to test for marijuana
intoxication: Blood, urine, and standardized field sobriety tests. This paper will also
examine an emerging technology, called the “Marijuana Breathalyzer,” which is
claimed to detect the trace amounts of THC in breath. Finally, this paper will
conclude that, to convict a person of DUI, the cumulative scientific evidence must
be indicative of actual impairment.
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INTRODUCTION & BACKGROUND
A forensic test that attempts to quantify marijuana intoxication for the purpose of DUI
prosecution must be scientifically accurate. This is because a person who is arrested for driving
under the influence of drugs or alcohol [hereinafter “DUI”] potentially faces devastating life
implications. Some of the penalties for DUI are imposed before an individual has had the
opportunity to address or refute the charge in a court of law. Administrative penalties, imposed
by a state’s Department of Motor Vehicles or its equivalent, are often based on an individual’s
failure of a roadside field sobriety test or refusal to take a sobriety test. 1 Though these
administrative penalties vary by state, one of the most common of them is the temporary
suspension of the individual’s driver’s license. 2 While many states may grant limited driving
privileges for certain purposes, such as driving to and from work, 3 the suspension of a driver’s
license may still seriously affect an individual’s employment and personal life. This penalty is

1

See, e.g. Driver Services: Driver Control, ARKANSAS DEPARTMENT OF FINANCE AND ADMINISTRATION,
https://www.dfa.arkansas.gov/driver-services/driver-control/ (last visited Oct. 3, 2018) (automatic six-month
suspension, after administrative hearing upon request, for first-offense driving while intoxicated or refusal to take
BAC test); Driving Under the Influence (FFDL 35), CALIFORNIA DEPARTMENT OF MOTOR VEHICLES,
https://www.dmv.ca.gov/portal/dmv/?1dmy&urile=wcm:path:/dmv_content_en/dmv/pubs/brochures/fast_facts/ffdl3
5 (last visited Oct. 3, 2018) (for first-time offenders, automatic four month suspension of driver’s license for failure
of chemical alcohol test and automatic one-year suspension for refusal to take a chemical test); Connecticut’s Drunk
Driving Law: Operating Under the Influence, CONNECTICUT DEPARTMENT OF MOTOR VEHICLES,
https://www.ct.gov/dmv/cwp/view.asp?a=813&q=249562 (last visited Oct. 3, 2018) (automatic 45-day suspension
of driver’s license for failure of chemical alcohol test or refusal to submit to a breath, urine, or blood test); Ohio
Department of Public Safety, Alcohol and Drug-Related License Suspension, OHIO BUREAU OF MOTOR VEHICLES,
https://www.bmv.ohio.gov/susp-ad-als.aspx (last visited Oct. 3, 2018) (automatic 90-day to five-year suspension for
failing a sobriety test and automatic one-five year suspension for refusal to take sobriety tests); Oregon Department
of Transportation, DUI Convictions: Suspensions, Hardship Permits, and Reinstatements, DRIVER AND MOTOR
VEHICLE SERVICES, https://www.oregon.gov/ODOT/Forms/DMV/6826.pdf (last visited Oct. 3, 2018) (automatic 90day suspension of driver’s license for failure of a breath or blood test and automatic one-year suspension for refusal
to take a breath or blood test).
2
See supra note 1 and accompanying text; see also Alcohol-Impaired Driving, GOVERNOR’S HIGHWAY SAFETY
ASSOCIATION, https://www.ghsa.org/state-laws/issues/alcohol%20impaired%20driving (last visited Oct. 3, 2018)
(“44 states, D.C., the Northern Mariana Islands and the Virgin Islands have administrative license suspension (ALS)
on the first offense. ALS allows law enforcement to confiscate a driver's license for a period if he fails a chemical
test.”).
3
See Alcohol-Impaired Driving, supra note 2.
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supplementary to any penalties that may be imposed by a court of law, which may include fines,
long-term or permanent revocation of driver’s license, or jail time.
These harsh penalties for drunken driving are a relatively new invention, stemming from
a stringent anti-drunk-driving campaign by Mothers Against Drunk Driving [hereinafter
“MADD”], an activist organization formed in 1980. MADD’s campaign fought for the
implementation of tougher drunk-driving laws. 4 Their campaign reframed the narrative of
drunken driving in American culture, focusing on the potential tragedy surrounding drunk
driving. 5 The campaign was successful, with states passing over 700 new drunk driving laws
between 1980 and 1985. 6 Since the 1980s, alcohol-related traffic fatalities have been greatly
reduced from 21,113 in 1982 to 10,497 in 2016. 7 In 2015, MADD updated its mission, stating
that it would also “help fight against drugged driving.” 8 In making this change, MADD wrote:
“While research and evidence remains unclear into the impacts of drugged driving, we do know
that the same tools and strategies that stop drunk driving will stop drugged driving, too.” 9
As MADD’s statement suggests, detection and prosecution of drugged driving currently
presents a serious political issue in the United States. This issue is exacerbated by the fact that
many political and lobbying groups are pressing for the federal legalization of the psychoactive
drug marijuana, both for medicinal and for recreational use. As of late 2018, thirty-one states and
the District of Columbia have all legalized the use of marijuana for medicinal purposes. Thirteen

4

Barron H. Lerner, Drunk Driving, Distracted Driving, Moralism, and Public Health, 365 NEW ENGL. J. MED. 879
(2011).
5
Inge B. Schmidt, Perpetual Trauma and Its Organizations: Mothers Against Drunk Driving and Drunk Driving
Revisited, 7 MEMORY STUDIES 239, 241 (2013).
6
Lerner, supra note 4, at 880.
7
National Highway Traffic Safety Administration, Traffic Safety Facts 2016, U.S. DEPARTMENT OF
TRANSPORTATION (2018), https://crashstats.nhtsa.dot.gov/Api/Public/ViewPublication/812554.
8
Drugged Driving, MADD, https://www.madd.org/the-solution/drugged-driving-prevention/ (last visited Oct. 9,
2018).
9
Id.
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states have decriminalized marijuana, 10 and nine have legalized it for recreational use. 11 Given
the potential for widespread use of marijuana in the United States in the future, a genuine
question exists as to what regulations need to be placed on its use by drivers. Some argue that
marijuana does not impair driving and does not need stringent regulation. Others believe that
marijuana DUI laws should be as strict as current alcohol DUI laws. To fully understand the
scope of this debate, and why it is important, one must understand what marijuana is, what its
psychoactive effects are, and whether it causes impairment to the extent that those who take it
should not be driving vehicles.
Marijuana is a mix of the dried leaves, stems, flowers, and seeds from the Cannabis
sativa plant. 12 Marijuana is a psychoactive drug that is often consumed for its recreational or
medicinal effects. The main psychoactive compound in the cannabis plant is ∆9tetrahydrocannibinol [hereinafter “THC”], 13 a cannabinoid. 14 When THC is smoked or
consumed, it produces several psychoactive effects. The experience depends on several factors,
including individual physiology, dosage, and environment. 15 THC generally produces a “high,”
where users can feel lightheaded, euphoric, calm, and relaxed. 16 Other symptoms include lack of
attention, focus, and vigilance, 17 poor retention of short-term memory, 18 impaired performance

10

German Lopez, The Spread of Marijuana Legalization, Explained, VOX (last edited Aug. 20, 2018),
https://www.vox.com/cards/marijuana-legalization/what-is-marijuana-decriminalization.
11
Jeremy Burke & Skye Gould, States Where Marijuana is Legal, BUSINESS INSIDER (Oct. 17, 2018),
https://www.businessinsider.com/legal-marijuana-states-2018-1.
12
RICHARD R. COMPTON, MARIJUANA-IMPAIRED DRIVING: A REPORT TO CONGRESS 4 (2017),
https://www.nhtsa.gov/sites/nhtsa.dot.gov/files/documents/812440-marijuana-impaired-driving-report-tocongress.pdf.
13
Id.
14
Leslie Iversen, Cannabis and the Brain, 126 BRAIN 1252, 1253 (2003).
15
Id. at 1261.
16
Id.
17
Id. at 1257, 1259, 1261.
18
Id. at 1257.
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on tests of balance and fine motor control, 19 drowsiness, 20 subjective enhancements of visual and
auditory perception, 21 perception of time passing more quickly, 22 and increased appetite. 23 The
subjective “high” and impairment peaks approximately 90 minutes after smoking, 24 though the
levels may vary based on several independent factors.
While some claim that they “drive better while high,” marijuana intoxication is
moderately linked to poorer driving performance. A meta-analysis based on nine studies,
including 49,411 participants in total, showed that there is twice the risk of motor vehicle
collision for operators who are under the influence of marijuana. 25 Marijuana-intoxicated drivers
can be aware of their impairments and are capable of attempting to compensate for perceived
impairments. 26 For example, the car-following task, a task which requires that drivers maintain
constant headway while following another car, is based on controlled information processing,
making it easier for marijuana-intoxicated drivers to compensate for perceived deficits in their
car-following while driving. 27 However, some impairments, such as those that relate to
autonomic brain functions or rapid decision-making, cannot be compensated for. Marijuana most
seriously impairs a driver’s reaction times, ability to concentrate, ability to respond appropriately
to urgent situations, and ability to track the position of other vehicles on the road. 28 Marijuana-

19

Id.
Id. at 1261.
21
Id. at 1258.
22
Id.
23
Id. at 1259–60.
24
COMPTON, supra note 12, at 7–8.
25
Percy Bondallaz et. al., Cannabis and Its Effect on Driving Skills, 268 Forensic Sci. Int. 92, 93 (2016) (citing
Mark Asbridge, Jill Hayden & Jennifer Cartwright, Acute Cannabis Consumption and Motor Vehicle Collision Risk:
Systematic Review of Observational Studies and Meta-Analysis, 344 BMJ 536 (2012)).
26
Id at 95.
27
Id. at 95, 100.
28
See id. (“Reaction time measurement, divided attention tasks (DAT), critical tracking tasks (CTT), or the response
to an urgent task appeared as mostly affected.” (internal citations omitted)). The ability to track multiple moving
objects is “thought to be integral to visual–motor coordination . . . and in the basic research, many have argued that
20
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impaired drivers also have inappropriate responses to emergencies, overblown reactions to
sudden sounds, and take more time than sober drivers to respond to road signals and brake
lights. 29 While studies often disagree on the actual degree of impairment that marijuana causes,
especially considering the diminished effects of marijuana on heavy users, 30 there is
demonstrated impairment to critical driving tasks and increased risk of accident, warranting that
marijuana use by drivers be controlled.
BODY
A. The Current Standards for Marijuana DUI Prosecution
The standards for proving marijuana DUI in the United States vary based on applicable
state laws. Some states, such as California, require that the state prove actual intoxication to
impose criminal liability. The California Vehicle Code, § 23152(f), states that it is “unlawful for
a person who is under the influence of any drug to drive a vehicle.” Proof that the defendant had
drugs in his or her system is not enough to prove DUI—the State must also prove that he or she
was “under the influence.” 31As noted by the California Supreme Court, to be found guilty under
§ 23152, “the ... drug(s) must have so far affected the nervous system, the brain, or muscles [of
the individual] as to impair to an appreciable degree the ability to operate a vehicle.” 32 To meet

multiple-object tracking is critical to driving an automobile . . . .” Martin Lochner & Lana Trick, Multi-Object
Tracking While Driving: The Multiple-Vehicle Tracking Task, 76 ATTENTION, PERCEPTION, & PSYCHOPHYSICS
2326, 2326 (2014).
29
R. Andrew Sewell, M.D., et. al., The Effect of Cannabis Compared with Alcohol on Driving, 18 Am. J. Addict.
185, 187 (2009)
30
See, e.g, Bondallaz et. al., supra note 25, at 95 (“Interestingly, other studies using [divided attention tasks]
observed no significant differences after acute THC intoxication in a cohort of heavy chronic cannabis smokers, or
even an improvement of daily cannabis users performances, suggesting an hypothetical adaptation to long-term
cannabis exposure.” (internal citations omitted)).
31
This contrasts with § 23152(b), which establishes a per se standard, stating that it is unlawful for any driver to
have a concentration of more than .08 alcohol in their blood, regardless of actual impairment.
32
People v. Canty, 32 Cal.4th 1266, 1277 (Ca. 2004) (quoting People v. Enriquez, 42 Cal.App.4th 661, 665 (Ca. Ct.
App. 1996)) (italics in original).
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this standard, California Police Departments train some police officers to become drug
recognition experts and have the officers perform a twelve-step examination to assess an
individual’s level of actual impairment. 33 The officers perform standardized field sobriety tests,
evaluate other physical signs, and occasionally instruct technicians to draw blood or collect urine
for forensic analysis. 34
Several states have established “per se” tests for marijuana DUI. Some give numerical
limits, while others use “zero tolerance” tests. In Colorado, Illinois, and Montana, for example, a
driver is per se intoxicated if he has more than 5ng/ml of THC in his blood. 35 Illinois law also
states that a driver is per se intoxicated if he has have more than 10ng/ml of THC in his saliva or
urine. 36 Fifteen states, such as Arizona, Delaware, Georgia, Indiana, and Pennsylvania, use zero
tolerance standards. 37 Any amount of THC or its metabolites found in the blood and/or urine is
considered a per se violation of the states’ respective DUI statutes. 38 The states that use per se
standards for DUI convictions rely heavily on forensic analysis. The states that require actual
impairment may rely less so on forensic evidence to secure convictions, but forensic evidence
may still be used to persuade the factfinder.
Reasoned decision-making in DUI cases must include an analysis of the accuracy and
usefulness of the forensic tests. While the admissibility and use of tests depends on the state,
there are three tests that are consistently used to prove intoxication both in and out of court:
blood tests, urine tests, and standardized field sobriety tests (SFSTs). Breath tests have recently

33

James Queally & Sarah Parvini, For Police, Catching Stoned Drivers Isn’t So Easy, L.A. TIMES (Mar. 22, 2018),
http://www.latimes.com/local/lanow/la-me-ln-marijuana-dui-20180322-story.html
34
Id.
35
COL. REV. STAT. § 42-4-1301; 625 ILCS 5/11-501(a)(7), 11-501.2(a)(6); MO. CODE ANN. § 61-8-411.
36
625 ILCS 5/11-501(a)(6).
37
COMPTON, supra note 12, at 15.
38
AZ REV. STAT. § 28-1381(A)(3); 21 DEL. C. § 4177(6); 40 GA. C. § 40-6-391(6); 9 IN. C. ANN. § 9-30-5-1(c); PA.
C.S. § 3802(d). See also COMPTON, supra note 12, at 15.
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gained popularity, perhaps due to their ease of use and their current widespread application to
test for alcohol intoxication. This paper will examine the strengths, weaknesses, and practical
applications of each of these four tests. 39 To facilitate understanding of the underlying reasons
for these strengths and weaknesses, this paper will also provide a brief overview of the chemical
structure of THC and its effects on the human body.
B. Chemical Attributes of THC and THC’s Effects on the Human Body
THC and other cannabinoids, such as the naturally produced endocannabinoid
anandamide, exert their psychoactive effects primarily by binding to and activating the
cannabinoid type 1 receptor [hereinafter “CB1”], a neuromodulatory receptor in the brain and
nervous system that is particularly abundant in the hippocampus, cortex, cerebellum, and basal
ganglia. 40 CB1 receptors generally modulate the release of neurotransmitters from axon
terminals. 41 When THC attaches to and activates the CB1 receptors, it inhibits the receptors’
release of neurotransmitters. 42 The neurotransmitters whose release is inhibited by THC include
“L‐glutamate, GABA, noradrenaline, dopamine, 5‐HT and acetylcholine.” 43 Though THC has
some form of inhibitory effect on dopamine, its use has been found to increase dopamine

39

THC and its metabolites are also detectable in hair and stool. Hair is not commonly used to detect THC, likely
because it is difficult to objectively quantify the consumption of marijuana with hair samples. See Michelle Taylor
et. al., Comparison of Cannabinoids in Hair with Self‐Reported Cannabis Consumption in Heavy, Light and Non‐
Cannabis Users, 36 DRUG ALCOHOL REV. 220, 225 (2017). Stool samples are not commonly used to test adults for
THC, though the reason is unclear. Hospitals will occasionally test the meconium of newborn infants to determine if
the infant was exposed to marijuana in-utero. See, e.g., A. Chittamma et. al., Detection of In Utero Marijuana
Exposure by GC–MS, Ultra-Sensitive ELISA and LC–TOF–MS Using Umbilical Cord Tissue, 37 J. ANALYTICAL
9
TOXICOLOGY 391, 391 (2013) (“Immunoassays for detecting cannabis abuse determine D -THC and its metabolites
in biological specimens such as . . . . meconium.”). This paper will not explore the validity of these tests due to their
lack of common use and popularity.
40
Rachel I. Wilson & Roger A. Nicoll, Endocannabinoid Signaling in the Brain, 296 SCIENCE 678, 678 (2002).
41
Iversen, supra note 14, at 1255.
42
Id.
43
Id.
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release. 44 As dopamine plays a key role in pleasure, reward, and behavioral reinforcement, 45 its
increased release may be one of the main causes of THC’s psychoactive effects. 46
After THC is consumed, 90% of it binds to the plasma and 10% binds to the red blood
cells. 47 Between 95-99% of the THC in the plasma binds to plasma proteins, the majority of
which are lipoproteins. 48 THC is capable of rapidly penetrating vascular tissues such as the liver,
lungs, and spleen, causing the THC in blood plasma to decrease relatively quickly after
consumption. 49 The liver metabolizes THC with microsomal hydroxylation, 50 converting THC
into the psychoactive 11-hydroxy-∆9-tetrahydrocannabinol [hereinafter “11-OH-THC”]. 51
Eventually, as the blood continues to circulate through the hepatic tissues, 11-OH-THC is further

44

See, e.g., Erik Oleson & Joseph F. Cheer, The Brain on Cannabinoids: The Role of Dopamine Release in Reward
Seeking, 2 COLD SPRING HARBOR PERSPECT. MED. 1, 1–3, 10 (2012) (finding that cannabinoids increase dopamine
release, though the signaling reasons are unknown). But see Mohamed Sherif et. al., Human Laboratory Studies on
Cannabinoids and Psychosis, 76 BIO. PSYCH. 526 (2016) (“[T]he HLS data remain mixed on whether cannabinoiddopaminergic interactions are involved in the acute effects of THC . . . .”).
45
R.A. Bressan & J.A. Crippa, The Role of Dopamine in Reward and Pleasure Behaviour – Review of Data from
Preclinical Research, 111 ACTA PSYCHIATR SCAND 14, 17 (2005) “[S]everal studies using animal models of reward
and measuring the in vivo release of dopamine with microdialysis reveal that natural rewarding stimuli such as food,
drink, sex and other pleasurable stimuli increase dopamine release in the nucleus accumbens.”).
46
See, e.g., Oleson & Cheer, supra note 44, at 1 (“All known drugs of abuse, including Δ9-tetrahydrocannabinol, the
primary psychoactive component of Cannabis sativa, increase dopamine concentrations in terminal regions of the
mesolimbic dopamine system . . . . Increases in nucleus accumbens dopamine are theorized to mediate the primary
positive reinforcing and rewarding properties of all known drugs of abuse.”).
47
Frank Musshoff & Burkhard Madea, Review of Biologic Matrices (Urine, Blood, Hair) as Indicators of Recent or
Ongoing Cannabis Use, 28 THER. DRUG MONIT. 155, 156 (2006).
48
Id.
49
Id.

50 Hydroxylation is the introduction of oxygen into an organic compound. RICHARD RENNIE, A DICTIONARY OF
CHEMISTRy, Hydroxylation (7th ed. 2016). Oxygen degrades the organic compounds that it is introduced to. This
hydroxylation is an important part of the liver’s processing of certain toxins, since it makes toxic substances that are
lipophilic more hydrophilic, and therefore more readily removed from the body by the kidneys. See, e.g., Xinsheng
Gu & Jose E. Manatou, Molecular Mechanisms Underlying Chemical Liver Injury, 14 EXPERT REV MOL MED 14
(2012). The liver performs hydroxylation using microsomes, vesicles containing enzymes that spur hydroxylation
reactions. A DICTIONARY OF ZOOLOGY, Microsome (4th ed. 2014). Cytochrome P450 (CYP), contained in liver
microsomes, is the main enzyme involved in the metabolization of THC. Kazuhito Watanabe et. al., Cytochrome
P450 Enzymes Involved in the Metabolism of Tetrahydrocannabinols and Cannabinol by Human Hepatic
Microsomes, 80 LIFE SCIENCES 1415, 1415 (2007). CYP P450 inserts one atom of oxygen into THC, converting
THC, C21H30O2, to 11-hydroxy-∆9-tetrahydrocannabinol, 21H30O3.
51
Musshoff & Madea, supra note 47, at 155–56.
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oxidized into the inactive 11-nor-tetrahydrocannabinol-9-carbolyxic acid [hereinafter “THCCOOH”]. 52 This phase-II metabolism involves the addition of glucuronic acid, which improves
the water solubility of the lipophilic THC and 11-OH-THC. 53 THC-COOH’s improved water
solubility assists the renal system with elimination, 54 though renal clearance of THC-COOH is
still low due to the extensive protein binding of cannabinoids. 55 Because THC is lipophilic, it
tends to accumulate in some less vascularized tissues, as well as in the body fat. 56 The THC in
the vascular tissues and fat is released into the blood over time and metabolized in the same
fashion, causing THC to have a lengthy half-life within the human body. 57
C. Tests Used for Detecting THC in the Body
Because of the unique characteristics of THC and the body’s methods of metabolizing it,
blood, urine, standardized field sobriety tests, and breath all have their own individual strengths
and weaknesses in accurately analyzing whether someone has smoked marijuana and, if so, how
much.
i.

Blood Tests

Blood tests for THC have a selective advantage compared to urine tests, as blood plasma
can contain both THC and THC’s metabolites. THC peaks in the plasma approximately eight
minutes after consumption, 11-OH-THC peaks at fifteen minutes after consumption, and THC-

52

Id.
See Marilyn A. Huestis, Humanoid Cannabinoid Pharmacokinetics, 4 CHEM. BIODIVERS. 1770 § 2.3 (2009)
(“Phase-II metabolism of THC-COOH involves addition of glucuronic acid . . . .Addition of the glucuronide group
improves water solubility, facilitating excretion . . . .”).
54
Id.
55
Id.
56
See Huestis, supra note 53, at § 2.2 (“With prolonged drug exposure, THC concentrates in human fat, being
retained for extended periods of time . . . .”); Musshoff & Madea, supra note 47, at 155 (“[THC] is rapidly
assimilated after exposure, and because of its lipophilic nature is distributed to adipose tissue, liver, lung, and
spleen. It is then slowly released back into the blood and metabolized, causing a relatively long terminal half-life.”).
57
See id. and accompanying text.
53
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COOH peaks at approximately 81 minutes after consumption. 58 By observing the levels of THC,
11-OH-THC, and THC-COOH in plasma from multiple samples taken at various times, one can
potentially pinpoint the time of consumption and the amount of consumption. 59 In addition,
blood tests for intoxicating substances already have a firm foothold in the United States legal
system. All 50 states have a set .08% blood alcohol concentration [hereinafter “BAC”] as the
legal limit for DUI, cementing BAC as the standard for determining intoxication. This legal
standard also correlates with scientific standards, as a person’s blood alcohol concentration
directly correlates to his level of impairment. 60 As discussed supra Part A, several states have
taken the example of the BAC legal limit and created per se limits of THC and/or its metabolites
in the blood, perhaps due to the success and relative ease of using the BAC legal limit.
There are several problems with drawing a direct correlation between BAC and blood
THC concentration [hereinafter “BTHCC”]. The first issue is a practical concern: Blood tests are
invasive, expensive, and time-consuming, and require consent or a warrant to be administered. 61
In addition, BTHCC has a shorter window of significant detectability, which may pass during

58 Priyamvada Sharma, Pratima Murthy & M.M. Srinivas Bharath, Chemistry, Metabolism, and Toxicology of
Cannabis: Clinical Implications, 7 IRAN J. PSYCH. 149, 157–58 (2012).
59
Marilyn Huestis, Allan Barnes & Michael Smith, Estimating the Time of Last Cannabis Use from Plasma Δ9Tetrahydrocannabinol and 11-nor-9-Carboxy-Δ9-Tetrahydrocannabinol Concentrations, 51 CLINICAL CHEM. 2289, 2290
(2005) (dosing thirty-eight test subjects with THC, testing their blood “2, 5, 10, 15, 20, 25, 30, 50, 70, 90, 110, and 235
min” after dosage, using predictive models to predict the time of last cannabis use using THC and THC-COOH
levels, and determining that for the first cigarette, “combined models gave time estimates that were 99.1% accurate
with no underestimates.”).
60
Nic Droste et. al., Comparing Levels of Blood Alcohol Concentration and Indicators of Impairment in Nightlife
Patrons, 37 DRUG & ALCOHOL REV. S348, S351 (2018) (“[T]he sum of observable intoxication symptoms and
levels of self‐ and interviewer‐rated intoxication was positively associated with BAC.”)
61
The Supreme Court recently found that due to the intrusiveness of blood test on the privacy interest, warrantless
blood tests that were taken without the presence of meaningful consent are unconstitutional under the Fourth
Amendment. The Court also found that the State cannot impose criminal penalties for refusing a warrantless blood
test. Birchfield v. North Dakota, 136 S.Ct. 2160, 2184, 2186 (2016).
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arrest, transportation, and processing, 62 unlike that of alcohol, which is metabolized at a constant
rate and stays in a person's system longer the more he has drunk. The BAC can also be
determined through a quick, portable breathalyzer test. Currently, there is not a quick, portable,
and well-tested method to detect THC levels roadside. 63
The second problem is that, while BAC’s peak in a person's blood is directly correlated
with his level of impairment, 64 the level of BTHCC is not. A person’s peak impairment and a
person’s peak BTHCC are not directly linked. 65 Peak cognitive impairment can occur almost 90
minutes after smoking, after the consecutive peaks of THC and all of its metabolites in the blood
plasma have been reached. 66 Given the fact that stopping a suspect, assessing his state, arresting
him, processing him, and booking him can easily take more than 90 minutes, police are likely to
be collecting blood samples that have long since passed the BTHCC peak. The implication is
that, in practice, police could collect blood samples from persons who are extremely intoxicated
from smoking marijuana, yet has very low levels of THC or its metabolites in their blood. This
places a great burden on the police and the prosecutor, as a blood test showing a low level of
THC can hinder their ability to make their case to the judge or the jury, even if they have other
evidence of actual impairment. 67 In contrast, if the police manage to apprehend and process a
person quickly, they can obtain a blood test that establishes a high level of THC or THC
metabolites, even if the person tested was not objectively intoxicated while he was driving. 68
This creates a situation in which those who are less likely to be impaired could be convicted for

62

The ideal window for detection of peak THC and its byproducts is, as discussed above, approximately 8–81
minutes. Sharma, supra note 58.
63
See infra Part A.iv for a discussion of a new technology, the “Marijuana Breathalyzer,” which attempts to serve
this function for police.
64
COMPTON, supra note 12, at 6.
65
Id. at 7.
66
Id. at 7–8.
67
Id. at 29.
68
Id. at 7 (“Peak THC level can occur when low impairment is measured . . . .”).
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DUI more frequently than they should, and those who are more likely to be impaired could be
convicted less frequently than they should.
Third, THC’s fat solubility leads it to be absorbed into the body’s fat cells and steadily
released into the blood over time. The levels of THC that exist in the fat can build up with
consistent use, with consistent marijuana users having significant amounts of THC stored in their
fat. 69 THC tends to be redistributed into the blood passively and in small amounts, but can be
redistributed into the plasma in larger quantities in conditions that promote lipolysis, such as
starvation, stress, 70 or exercise. 71 In human fat biopsies, THC has been been observed up to 28
days after the final exposure to marijuana. 72 In a study of consistent marijuana users, both THC
and THC-COOH were detectable in the blood plasma for up to thirty-three days after exposure. 73
While THC and THC-COOH levels were inconsistent from day to day, perhaps due to variability
in individual lipolysis over the month-long study, two of the twenty-two subjects had .3 μg/L (or
.3 ng/ml) of THC in their blood after 30 days, and one had .7 μg/L (.3 ng/ml) of THC-COOH in
his blood after 33 days. 74 Of the blood samples from consistent users, 44% were THC-positive

69

Id.
One study administered daily injections of THC to rats and either administered ACTH, a hormone released in
response to stress or deprived them of food. The researchers varied the amount of ACTH administered and when,
the amount of time the THC was administered for, and the “washout period,” among the various groups of rats in the
study. Generally, the rats that were administered ACTH and the rats that were food deprived both had significantly
increased blood THC concentrations compared to the control rats. Gunasekaran et. al., Reintoxication: The Release
9

70

of Fat-Stored D -tetrahydrocannabinol (THC) Into Blood is Enhanced By Food Deprivation or ACTH Exposure,
158 British J. Pharmacology 1330, 1330–35 (2009).
71
A study of regular cannabis users showed that moderate exercise increases THC blood concentration in regular
marijuana users. Fasting for 12h did not increase THC blood concentration, though the researchers theorized that
more extended fasts may increase lipolysis and cause higher concentration. Alexander Wong et. al., Exercise
Increases Plasma THC Concentrations in Regular Cannabis Users, 133 DRUG AND ALCOHOL DEPENDENCE 763,
766–67 (2013).
72
Eva Johansson et. al., Determination of Δ1‐tetrahydrocannabinol in Human Fat Biopsies From Marihuana Users
by Gas Chromatography–Mass Spectrometry, 3 BIOMED. CHROMATOGRAPHY 35, 38 (1989).
73
Mateus M. Bergamaschi et. al., Impact of Prolonged Cannabinoid Excretion in Chronic Daily Cannabis Smokers’
Blood on Per Se Drugged Driving Laws, 59 CLIN. CHEM. 519, 523 (2013).
74
Id. at 522–23.
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through day 16, 75 and 85% of the samples were positive for THC-COOH through day 22. 76
Though the numbers observed were generally too low to meet the 5ng/ml thresholds established
in some states, they would be sufficient to prove per se DUI in zero-tolerance states, and could
be used as evidence of DUI in states that have not yet established specific numerical standards
for marijuana intoxication. While researchers have stated that some subjects showed “persistence
of THC impairment” throughout the study, the researchers’ definition of “impairment” was
based on per se limits that had been observed in earlier studies, not on observations of the
subjects’ actual impairment. 77
These limitations do not necessarily mean that blood tests cannot ever be used as
evidence for DUIs. As discussed earlier, 78 due to the body’s methods of metabolizing THC, the
presence of certain concentrations of THC, 11-OH-THC, and THC-COOH may be able to
indicate approximately the time and amount of consumption. However, due to the limitations, it
is difficult, if not impossible, to equate BTHCC with actual intoxication. For this reason, blood
tests for THC or its metabolites should only be used as a supplement to other scientific tests and
other evidence, not as sufficient evidence of impairment in and of themselves. This necessarily
means that per se and zero tolerance statutes should not use blood tests to charge or prosecute
DUIs, due to the potential for serious errors in their application.
ii.

Urine Tests

75

Id. at 521, 523.
Id. at 523.
77
Id. at 524. See id. at 521, 524 (“Cannabinoid blood detection rates were calculated at the limits of . . . . lower
range of a per se THC limit for defining performance impairment above which drivers are at increased risk for motor
vehicle accidents . . . . However, additional research is warranted on . . . and the relationship between concentrations
in blood and brain (the site of action of impairment).”).
78
See supra note 59 and accompanying text.
76
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Urine testing is the most common scientific method for detecting marijuana usage, both
in the public and in the private worlds, as the test is noninvasive and the sample is generally easy
to collect. 79 There are two potential ways of testing urine for drugs: screening tests, using
immunoassay technology; and confirmatory tests, using gas chromatography/mass
spectrometry. 80 Immunoassays use antibodies to detect drug metabolites, such as THC-COOH,
that are present in the urine, though they are limited by the fact that some substances in the urine
can have similar characteristics, possibly leading to false positives or negatives. 81 Confirmatory
tests use gas chromatography/mass spectrometry to identify the specific chemical structures that
are present in urine and to quantify the actual amounts of the metabolite in the sample. 82 The
Department of Health and Human Services has a “cutoff concentration,” requiring that a sample
contain 50 ng/ml of THC-COOH in the immunoassay and 15 ng/ml in the confirmatory test to be
considered positive for marijuana metabolites. 83 This is for the purpose of employee drug
testing, 84 and does not apply to federal or state governments. In zero tolerance states that allow
urine testing, for example, any amount of THC-COOH in the urine could hypothetically result in
a DUI conviction.
One of the most controversial issues raised by testing for THC-COOH is its long
detection window. Though studies have varied in their conclusions as to how long THC-COOH
is excreted through the urine after consumption, it is commonly believed that THC-COOH can
be excreted for a month or more. A fact sheet prepared for drug-court practitioners referred to

79

Karen E. Moeller et. al., Clinical Interpretations of Urine Drug Tests: What Clinicians Need to Know About Drug
Screens, 92 MAYO CLIN. PROC. 774, 775 (2017).
80
Id.
81
Id.
82
Id.
83
Id. at 775–76.
84
Id. at 776.
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this window as the “30-plus day elimination assumption,” which they described as a “widespread
and longstanding” assumption held by judges, attorneys, and the public alike. 85 The fact sheet
was critical of the 30-plus day elimination assumption, stating that “[s]tudy subjects with
exceptionally long cannabinoid detection times (30-plus days) were just that—exceptional.” 86
The fact sheet identified potential weaknesses in the studies that identified a 30-plus day
detection window, including the use of chronic and heavy marijuana users as test subjects, 87 the
use of outdated technologies that do not reflect the current capabilities of immunoassays, 88 a lack
of monitoring subjects during testing, which may have allowed them to use marijuana while the
study was being conducted, 89 and the use of cannabinoid cutoff concentrations that are lower
than what a criminal justice program would use. 90 The fact sheet concluded that a 50 ng/ml
cutoff level would be appropriate for chronic users, as it would be unlikely for 50 ng/ml of
cannabinoids to appear in the urine longer than 10 days after smoking, and a 20 ng/ml cutoff for
occasional or single-use users, as it would be unlikely for 20 ng/ml to appear in the urine longer
than 7 days after smoking. 91 As for any potential “exceptional” cases, such as a person’s
extended and ongoing marijuana use over a period of years, the burden would fall on that person
to prove such use and to demonstrate that such use led to an inaccurate portrayal of

85

Paul Cary, The Marijuana Detection Window: Determining the Length of Time Cannabinoids Will Remain
Detectable in Urine Following Smoking, NATIONAL DRUG COURT INSTITUTE, at 1 (April 2006), available at
https://www.ndci.org/sites/default/files/ndci/THC_Detection_Window_0.pdf.
86
Id. at 7.
87
See id. at 5, Table 5 (outlining “self-reported as chronic users” as a “[f]actor[] [p]otentially [a]ffecting the
[r]elevance of [s]tudy [f]indings “ for four academic studies).
88
See id. at 6 (“[T]he results of cannabinoid elimination investigations performed in the 1980’s may no longer be
applicable to estimating the detection window for marijuana in urine using today’s testing methodologies.”).
89
See id. (“The most serious of these obfuscating factors is the inability to assure marijuana abstinence of the
subjects during the studies.”).
90
See id. (“Other study design issues that may limit their usefulness include the use of detection methods with
cannabinoid cutoff concentrations far below those traditionally utilized in criminal justice programs . . . .”).
91
Id. at 9. Note that, though the fact sheet recommends these numbers, these are not requirements set by the
legislature. The cutoffs can be much lower, or much higher, in court.
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intoxication. 92 To evaluate the argument that the fact sheet makes for the standards of marijuana
urine testing, it is important to first consider the criticisms that it directs to the studies that came
before it.
First, the fact sheet notes as a potential limitation that “[s]tudies of chronic marijuana
users reporting prolonged cannabinoid excretion profiles have provided the basis for the common
[30-day] assumption . . . .” 93 Though the majority of studies concerning testing for THC,
including urine testing studies, appear to use chronic users or at least occasional users as test
subjects, 94 that choice may not be inappropriate in evaluating the efficacy of testing for DUI
purposes. In 2017, the Center for Behavioral Health Statistics and Quality surveyed 272,103
persons in the United States aged 12 or older. 95 Table 1 below shows the results of the survey.
Survey of Persons in the United States Aged 12 or Older
Used Marijuana in Entire Lifetime

122,943

Used Marijuana in the Past Year

40,935

Used Marijuana Daily or Almost Daily in the Past Year

8,123

Used Marijuana in the Past Month

25,997

Used Marijuana Daily or Almost Daily in the Past Month

10,829

Table 1, showing data compiled on the demographic information of cannabis users. Dark grey identifies the subset of
users who could be categorized as “chronic” users and light grey identifies the users who appear to be developing a
pattern of chronic use. 96

92

Id.
Id. at 6.
94
This may be due to the fact that it is an ethical violation to expose heathy non-cannabis users to a potentially
dangerous and addictive drug.
93

95 Results from the 2017 National Survey on Drug Use and Health: Detailed Tables, at Table 12.2A, CENTER FOR
BEHAVIORAL HEALTH STATISTICS AND QUALITY, https://www.samhsa.gov/data/sites/default/files/cbhsqreports/NSDUHDetailedTabs2017/NSDUHDetailedTabs2017.htm (last visited Oct. 18, 2018).
96
Id. at Tables 1.16A, 1.69A, 6.1A & 7.1A.
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Of the 66,932 total marijuana users who had smoked marijuana within the last year or the
last month, approximately 12% could be defined as “chronic” users, and approximately 16%
could be defined as progressing towards becoming chronic users. Though the CBHSQ’s survey
is not directly scalable to the entire United States population, these statistics show that chronic
users make up a statistically significant percentage of all marijuana users. Because of THCCOOH’s long elimination period, chronic users are more likely to test positive for THC-COOH
than light users, and therefore are likely to make up a more-then-representative percentage of
those who test positive for THC-COOH when taking a urine test.
Second, the fact sheet notes two limitations that are related to the structure of the studies
themselves: Lack of proper monitoring of users to control for ongoing marijuana use, and the use
of outdated testing technologies. 97 Studies that were carried out after 2006, when the fact sheet
was written, and that followed appropriate monitoring protocols, eliminate these stated
limitations. In addition, the fact sheet notes that studies should use high cutoffs for THC levels to
reflect the fact that drug courts will prosecute those with higher THC levels. 98 Therefore, an
appropriate study will use a less sensitive cutoff for the test to be “positive.”
A study by Robert S. Goodwin et. al. in 2008 performed urine tests on sixty healthy
cannabis users between the ages of 18–45. 99 The mean number of years the subjects had smoked
marijuana was 11.2 ± 6.4, and the subjects smoked a mean of 9.4 with a standard deviation of
[hereinafter “±”] 9.7 joints/week. 100 The subject were divided into three groups: 0–50 ng/mg 101

97

Cary, supra note 85, at 6.
Id.
99
Robert S. Goodwin et. al., Urinary Elimination of 11-Nor-9-carboxy- 9-tetrahydrocannnabinol in Cannabis
Users During Continuously Monitored Abstinence, 32 J. ANAL. TOX. 562, 563 (2008).
100
Id. at 563.
101
Id. at 566 (nineteen subjects).
98
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51–150 ng/mg, 102 and >150 ng/mg 103 initial creatinine-corrected THC-COOH concentration. 104
All participants had positive urine cannabinoid tests of >50 ng/ml upon intake. 105 The subjects
resided in a closed research facility with 24h monitoring during a maximum thirty-day
abstinence period. 106 Urine tests were taken randomly over the subjects’ days of residence, with
a 50ng/ml cutoff to test positive. The researchers noted that during the elimination period,
samples of urine could test positive, negative, then positive again. 107
The results showed that, as the initial TCH-COOH concentration increased, the mean
days it took to test positive increased. However, there was still a significant amount of variation
within and among the groups. In the 0-50ng/mg group, the mean day of the first negative
specimen was 0.6 ± .08 days, and the mean day of the last positive specimen was 4.6 ± 5.6
days. 108 The range of days for the last positive specimen was between 0–21 days. 109 In the 51–
100ng/mg group, the mean day of the first negative specimen was 3.2 ± 2.8 days, and the mean
day of the last positive specimen was 9.7 ± 6.4 days. 110 The range of days for the last positive
specimen was between 1.8–25.3 days. 111 In the >150ng/mg group, the mean day for the first
negative specimen was 4.7 ± 4.8 days, and the mean day of the last positive specimen was 15.4 ±
9.8 days. 112 The range of days for the last positive specimen was between 3.6 and 29.6. 113 0–50
ng/mg had detection rates between ~5-60% within the first 7 days of the first negative test. 114

102

Id. (twenty-one subjects).
Id. at 567 (twenty subjects).
104
Id. at 566.
105
Id. at 563.
106
Id.
107
Id. at 562.
108
Id. at 565, T.2.
109
Id.
110
Id. at 566, T.2.
111
Id.
112
Id.
113
Id.
114
Id. at 568, Fig. 2.
103
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51–100 ng/mg had detection rates between ~0%-75% within ~22–23 days of the first negative
test. 115 >150 ng/mg had detection rates between 60%-100% for 28 days after the first negative
test. 116 The researchers found a significant correlation between BMI and extended periods of
time until last positive test. 117
The study shows that the number of days that THC-COOH can be detected in the urine
depends generally upon the initial concentration of THC-COOH in the body. The initial
concentration appears to depend upon the average number of joints smoked per week, 118 as well
as how many days the subject smoked in the two weeks before testing. Table 2 below shows the
relevant demographic information for members of each category. 119
0 to 50 ng/mg Concentration
Subject

Joints/Week

Days Used in
Last 14 Days

115

Years Used

Initial
Concentration
of THCOOH

Time of Last
Positive
Specimen

Id.
Id. at 567.
117
See id. at 568 (“BMI was significantly correlated with the day of the last positive specimen (i.e., the greater the
BMI, the longer the interval until the last positive specimen was produced).”
118
“Joints” vary in concentration of THC, depending on the type and quantity of cannabis used. For the purposes of
this paper, it is assumed that the variation was normalized by the number of persons in the study and by the limited
geographic area that the study encompassed.
119
These numbers were not calculated by the researchers in the original study. These numbers were calculated by
this paper’s author by comparing Table 1’s demographic characteristics of test subjects to Table 2’s information
about which subjects were in which categories. The numbers were tallied, excluding information from participants
who did not include the relevant information, and the approximate mean was calculated from those numbers. Such
calculations work as only rough approximations of the kinds of demographic information that may be linked to
initial THC-COOH concentrations, as such specific data is currently lacking. See, e.g., id at 564–66, T.1 & T.2.
116
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A
B
C
E
H
L
AA
BB
DD
EE
GG
LL
MM
OO
RR
TT
ZZ
DDD
FFF

2
10
12
3
11
N/A
0
4
9
N/A
8
12
3
2
1
1
6
N/A
15

4
10
14
7
11
1
0
5
14
N/A
14
14
0
9
10
1
14
N/A
14

8
25
9
24
8
11
28
25
17
N/A
20
5
15
10
10
6
9
N/A
8

47.3
30.1
34.6
9.8
46.8
27.8
11.6
1.8
0
40.4
15.7
24.8
32.1
29.5
34.4
15.5
43.4
5.1
0

4.3
1.5
3.8
2.2
1.2
0
0.7
N/A
N/A
3.3
2.4
21.8
N/A
5.6
3.8
N/A
8.6
N/A
N/A

6.2 ± 4.8

8.4 ± 4.5

14 ± 7.6

23.7 ± 15.94

4.6 ± 5.7

51 to 150 ng/mg Concentration
Subject

Joints/Week

Days Used in
Last 14 Days

Years Used

Initial
Concentration
of THCOOH

Time of Last
Positive
Specimen

D
F
G
J
K
N
R
S
V
W
Y
CC
FF
HH
JJ
NN
QQ
WW
XX
CCC
HHH

8
6
1
4
16
24
6
3
6
12
6
3
6
N/A
3
3
4
15
5
6
7

14
14
9
3
14
14
14
14
6
12
14
5
7
N/A
8
10
14
14
10
14
14

12
10
11
17
N/A
8
6
10
7
13
4
17
22
7
9
15
4
8
12
5
22

133.5
101
70.2
74.6
120.8
90.6
142.2
96
62.6
78.9
83.7
114.9
61.9
101.4
96.1
120.7
110
110.2
92.3
71
109.2

4.3
3.1
1.8
11.6
8.3
3.3
10.1
3.7
8.9
2.6
16
3.8
25.3
11
11
12.1
10.7
20.9
17
5
13.3
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7.2 ± 5.6

11.2 ± 3.7

11 ± 5.4

97.2 ± 22.6

7. ± 6.4

> 150 ng/mg Concentration
Subject

Joints/Week

Days Used in
Last 14 Days

Years Used

Initial
Concentration
of THCOOH

Time of Last
Positive
Specimen

I
M
O
P
Q
T
U
X
Z
II
KK
PP
SS
UU
VV
YY
AAA
BBB
EEE
GGG

10
18
4
N/A
6
6
4
12
60
13
11
8
6
1
30
9
24
12
9
30

14
13
13
14
8
14
10
14
14
13
14
6
10
6
14
14
14
14
8
14

17
7
24
N/A
4
9
10
13
16
9
5
2
6
8
12
7
8
3
5
4

364.6
155.1
171.7
279.1
158.4
681.9
190.5
171.8
248.5
425.2
315.3
155.7
181.3
333.5
176.8
668.1
323.3
286.9
341.4
1165.9

12.7
6
3.6
8.2
3.6
29.8
29.3
14.7
6.3
11
11
6.7
8.8
18.9
27.3
29.2
28.5
29.8
12
11

14.4 ± 13.8

12.1 ± 2.9

8.9 ± 5.5

339.8 ± 247.3

15.42 ± 9.8

Table 2, showing data compiled on the demographic information of marijuana users whose urine was tested for levels of THC. 120

In the 0–50ng group, the subjects smoked a mean of 6.2 ± 4.8 joints per week, smoked a
mean of 8.4 ± 4.5 of the 14 preceding days, and had been smoking for a mean of 14 ± 7.6
years. 121 The numbers ranged from 0–12 joints/week, smoking 0–14 of the preceding days, and
5–28 years of smoking history. 122 In contrast, in the >150 ng group, the subjects smoked a mean
of 14.4 ± 13.8 joints per week, smoked a mean of 12.1 ± 2.9 of the 14 preceding days, and had

120

Id.
Id. at 564–66, T.1 & T.2; see also Table 1.
122
Id. at 564–66, T.1 & T.2.
121
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been smoking for a mean of 8.9 ± 5.5 years. 123 The numbers ranged from 1–60 joints/week,
smoking 6–14 of the preceding days, with 7–24 years of smoking history. 124 The exact way that
these variables interact is unclear. Some appear to be more significant than others, though
information about these interactions is currently lacking. Development of a mathematical model
may be helpful in determining the demographics behind initial THC-COOH concentration in the
future.
Comparisons between similar and dissimilar subjects in the same groups can show how
demographic factors can conflict with one another and cause differing results. Table 2 below
shows the variability in results between subjects. Joints/week, days used in the 14 days before
the study, and the initial concentration of THCOOH all appear to be important variables, as the
numbers trended upwards as the time of last positive specimen trended upwards. 125 However, as
shown below, these variables did not serve as consistent or reliable predictors of the time of last
positive specimen.
0-50 ng/mg Concentration
Subject

Joints/Week

Days Used in Last
14 Days

Years
Used

Initial Concentration
of THCOOH

Time of Last
Positive
Specimen

B

10

10

25

30.1

1.5

LL

12

14

5

24.8

21.8

Initial Concentration
of THCOOH

Time of Last
Positive
Specimen

51-100 ng/mg Concentration
Subject

Joints/Week

Days Used in Last
14 Days

Years
Used

123

See supra note 121 and accompanying text.
Id. at 564–66, T.1 & T.2.
125
See Table 1, showing that the mean joints/week, days used in last 14 days, and initial concentration of THCOOH
trended upwards along with the mean time of last positive specimen.
124
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F

6

14

10

101

3.1

FF

6

7

22

61.9

25.3

> 150 ng/mg Concentration
Subject

Joints/Week

Days Used in Last
14 Days

Years
Used

Initial Concentration
of THCOOH

Time of Last
Positive
Specimen

T

6

14

9

681.9

29.8

GGG

30

14

4

1165.9

11

Table 3, showing the variable results of users with similar demographic information in the same groups. 126

Though the exact findings of this study may warrant future explanation and testing, it
shows that the thirty-day detection window is still a possibility for heavy cannabis users. While
the fact sheet states that it is “unlikely” for more than 50 ng/ml of THC-COOH to appear in a
heavy THC users’ urine more than 10 days after consumption, 127 the 2008 study reported that
detection rates for very heavy users ranged from 60-100% over 28 days. 128 There were
detections of 50 ng/ml of THC-COOH in the urine at 20.9 days, 21 days, and 25.3 days for two
chronic, but not heavy, users. 129 While the fact sheet may well be correct in stating that the 30day detection window is “extraordinary,” this study shows that a positive test within this window
is far from uncommon. One must question if an estimate of 50 ng/ml for heavy users is a
“reasonable estimate” if it risks implicating a person for DUI who has been abstaining from
marijuana use for over three weeks.
iii.

Standardized Field Sobriety Tests

126

Id. at 564–6, T.1 & T.2.
Cary, supra note 85, at 9.
128
Goodwin, supra note 101, at 567.
129
Id. at 566.
127
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Standardized Field Sobriety Tests [hereinafter “SFSTs”] are widely used by police to
detect a person’s impairment. Of all the tests that are currently used by police to test for
marijuana intoxication, SFSTs are the only tests that attempt to measure a person’s actual level
of impairment and intoxication. They do so by causing the subject to engage in certain behaviors,
in order to observe and assess his or her motor skills, balance, attention, and other cognitive
functions. There are three main SFSTs: Horizontal Gaze Nystagmus [hereinafter “HGN”], “Walk
and Turn Away,” and the “One Leg Stand.” 130 Generally, if the subject shows impairment during
two out of three of these SFSTs, he is classified as impaired on the overall SFST. 131
HGN is an involuntary jerking movement of the eye. 132 This jerking movement of the eye
is a result of the nervous system’s temporary loss of control of the ocular muscles. 133 Because of
the way the eye is connected to the orbit, if the ocular muscles are not being actively controlled
by the nervous system, the eyes return to their primary gaze, which is staring straight ahead. 134
The neural integrator controls these opposing ocular muscles, allowing the eye to focus the retina
on stationary targets, track slowly-moving objects through use of the “smooth pursuit system,” or
perform saccades, which are rapid, “explosive burst[s]” of eye movement that are used to change
the object of fixation or track objects that are moving too quickly to be tracked by the smooth
pursuit system. 135 Certain anomalies in the nervous system, such as the deficits created by

130

Luke A. Downey et. al., The Standardized Field Sobriety Tests (SFST) and Measures of Cognitive Functioning,
86 ACCIDENT ANALYSIS & PREVENTION 90, 91 (2016)
131
Id. at 92.
132
Id. at 91.
133
See Steven J. Rubenzer & Scott Stevenson, Horizontal Gaze Nystagmus: A Review of Vision Science and
Application Issues, 55 J. FORENSIC SCI. 394, 395 (2010) (“Once the eyes find a stationary target, they must be
maintained in the correct position. This requires the correct balance of muscle tone among the three pairs of
opposing ocular muscles in each eye . . . Without continual input from the neural integrator (part of the oculomotor
control center), the eyes cannot be held away from primary gaze (straight ahead).”).
134
Id. at 395.
135
Id. at 394–95.
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alcohol, can cause the neural integrator to briefly lose control of the ocular muscles, making the
eyes drift away from the target and back towards the primary gaze. 136 Once this error is caught,
the neural integrator will initiate a saccade to focus the retina back on the target. 137 The drift of
the eyes off of the target, and the subsequent refocusing through the saccade, is gaze
nystagmus. 138
When a person is sober, HGN occurs when his eyes are gazing to the side at high
peripheral angles, stressing the ocular muscles. 139 When a person is intoxicated, due to the
intoxicating agents’ effects on the nervous systems, the HGN will be more exaggerated,
occurring at less extreme angles and during more regular eye movements. 140 To perform the test,
the police officer will hold an object, move it slowly in front of the subject’s face, and tell the
subject to follow its movement with his eyes. A sober, healthy, and focused person can follow
the object with smooth eye movements. 141 In an intoxicated person, the eyes may be incapable of
following the object smoothly, may jerk at maximum deviation, and may jerk within 45° of
center. 142
Some have questioned the accuracy of the HGN test. Nystagmus can also be caused by a
variety of conditions that are not related to intoxication, such as poor lighting, distractions such
as wind or traffic, various types of medical conditions, anxiety, circadian rhythms, and fatigue. 143

136

Id. at 395.
Id.
138
Id.
139
Wendy Bosker et. al., A Placebo-Controlled Study to Assess Standardized Field Sobriety Tests Performance
During Alcohol and Cannabis Intoxication in Heavy Cannabis Users and Accuracy of Point of Collection Testing
Devices for Detecting THC in Oral Fluid, 223 PYSCHOPHARMACOLOGY 439, 442 (2012).
140
See id. (“However, when a person is impaired by alcohol, nystagmus is exaggerated and may occur at lesser
angles.”).
141
Id.
142
Id.
143
Steven Rubenzer, The Standardized Field Sobriety Tests: A Review of Scientific and Legal Issues, 32 LAW HUM.
BEHAVIOR 293, 299; Steven Rubenzer & Scott Stevenson, supra note 135, at 396.
137
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In a study testing correlations between performance on SFSTs and performance on other
cognitive tests, there was a strong positive relationship between “lack of smooth pursuit,” lower
vigilance, and impaired choice reaction time, perhaps because impairments in the smooth pursuit
system and the neural integrator are symptomatic of overall impairment in fine motor control. 144
However, no other significant associations were found between the HGN and impaired cognitive
performance, and the test found that there was a significant amount of variation in identification
of intoxicated individuals using HGN. 145 One paper outright suggested that the HGN test is
“flawed” and “based on fraud,” suggesting that “the Horizontal Gaze Nystagmus (HGN), the
cornerstone of the test battery was fundamentally flawed and that the HGN test was improperly
conducted by more than 95% of the police officers who used it to examine drivers . . . .” 146
Despite these issues, the HGN remains a popular way for police and other authorities to evaluate
intoxication.
“Walk and Turn Away,” sometimes referred to as the “Walk the Line” test, is a divided
attention task, used to test motor skills, balance, and focus. The officer instructs the subject to
take nine steps, heel to toe, along a straight line. 147 The subject must then turn on one foot and
return by taking nine heel-to-toe steps in the same direction. The test looks for eight specific
indicators of impairment: “participant cannot keep balance while listening to the instructions,
participant begins before the instructions are finished, participant stops while walking to regain
balance, participant does not touch heel-to-toe, participant steps off the line, participant uses
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arms to balance, participant makes an improper turn, or takes an incorrect number of steps.” 148
The “Walk and Turn Away” test has high false positive rates, with two studies reporting an
overall 37% false positive rate, one study reporting an overall 72% false positive rate, and one
study reporting a 50% false positive rate for subjects at .00% BAC. 149 “Walk and Turn Away”
has been found to be substantially correlated with BAC, with a mean 55% correlation with
impairment. 150 The reason why the test may have so many false positives because of a lack of
consideration for people who are older, overweight, physically inactive, or otherwise physically
impaired. 151
The “One Leg Stand” tests for cognitive and motor impairment. The officer directs the
subject to stand on one leg, with the other raised ~15 cm off the ground, and count aloud from
1000. 152 The test lasts for approximately 30 seconds. The officer looks for swaying while
balancing, the subjects’ use of their arms to retain their balance, hopping to maintain balance,
and putting the raised foot down to regain balance. The officer also measures how long it takes
the subject to count to 1,030. 153 The test has a lower correlation with BAC than the “Walk and
Turn Away Test,” with a 45% correlation, but has demonstrated lower false positive rates than
the “Walk and Turn Away” test, with an average 16% false positive rate when determining a
BAC of .10%. 154
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Though SFSTs have been used to test for intoxication and BAC since their development
and implementation in 1981, 155 their potential use to detect marijuana intoxication has not been
extensively studied. A 2005 study, attempting to resolve the question as to whether performance
on SFSTs can be used to assess impairment due to THC consumption, dosed forty cannabis users
with placebos, low-dose, and high-dose THC and assessed their impairment through the three
standard SFSTs and a driving simulator. 156 One of the tests performed was the HGN and a
closely related test, the vertical gaze nystagmus test. 157 The researchers told the subjects to focus
on an object located 12–15 inches in front of their faces and moved the object horizontally and
vertically. The investigator looked for “lack of smooth pursuit . . . distinct nystagmus at
maximum deviation .. . . nystagmus onset before 45˚ . . .and nystagmus at the vertical position
(VGN) . . . .” 158 The researchers also added an additional criterion to the HGN/VGN, “head
movements or jerks . . . .” 159 The researchers also used the “walk and turn away” and “one leg
stand” tests. 160 SFSTs were administered 5 minutes after smoking (SFST Time 1), 55 minutes
after smoking (SFST Time 2), and 105 minutes after smoking (SFST Time 3). 161 Driving tests
were administered 30 minutes after smoking (Driving Time 1) and 80 minutes after smoking
(Driving Time 2). 162
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Subjects who took driving tests at Driving Time 1 were not considered to be significantly
impaired, though they did straddle solid and barrier lines at frequencies which approached
statistical significance. 163 As driving was only significantly impaired at Driving Time 2, the
researchers only analyzed SFST Times 2 and 3 to determine if the subjects’ performance on the
tests was correlated with driving impairment. 164 The subjects were further divided up into four
categories: High-dose THC participants who were impaired on Driving Test 2, high-dose THC
participants who were not impaired on Driving Test 2, low-dose THC participants who were
impaired on Driving Test 2, and low-dose THC participants who were not impaired on Driving
Test 2. The results, as shown in Table 4 below, indicated that the SFSTs could detect THC
intoxication with 84-100% accuracy at both testing times, but also resulted in extremely high
degrees of false positives. 165
SFST Time 2, 55 Minutes After Smoking
Driving-Impaired, High-Dose THC

92% correctly identified as impaired

Non-Driving-Impaired, High-Dose THC

84.6% incorrectly identified as impaired

Driving-Impaired, Low-Dose THC

88.5% correctly identified as impaired

Non-Driving-Impaired, Low-Dose THC

61.5% incorrectly identified as impaired

SFST Time 3, 105 Minutes After Smoking
Driving-Impaired, High-Dose THC

84% correctly identified as impaired

Non-Driving-Impaired, High-Dose THC

38.5% incorrectly identified as impaired

Driving-Impaired, Low-Dose THC

100% correctly identified as impaired
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Non-Driving-Impaired, Low-Dose THC

100% incorrectly identified as impaired

Table 4, showing data compiled on the efficacy of using SFSTs to determine intoxication. 166

Based on this data, the study concluded that the SFSTs were capable of correctly
identifying marijuana-related driving impairment. 167 The Walk and Turn test was considered to
be the best predictor of driving ability for low-dose cannabis, and the One Leg Stand was
considered to be the best predictor of driving ability for high-dose cannabis, 168 suggesting that
SFSTs that assess impairments in balance and attention are therefore the best predictors of
marijuana-related driving impairment. However, the researchers noted that the frequent
classification of non-impaired participants as impaired may be an indication that the SFSTs are
more capable of detecting THC consumption than actual impairment. 169 Though ultimately
positive on the use of SFSTs to test for marijuana-related driving impairment, the researchers
warned that “that in real-world scenarios, the amount of false positives could be quite high if the
SFSTs alone are used to determine whether an individual is driving under the influence of
drugs.” 170
Other studies have been less positive about using SFSTs to test for marijuana
intoxication. A 2012 study, conducted on heavy cannabis users, showed that the overall score on
the SFSTs did not successfully discriminate between baseline and impairment. 171 Of all the tests,

166

Id.
See id. (“When driving performance was impaired, a greater number of SFST signs were observed than when
driving performance was not impaired.”).
168
Id.
169
Id.
170
Id. at 177.
171
Wendy M. Bosker et al., Medicinal Δ9‐Tetrahydrocannabinol (dronabinol) Impairs On‐the‐Road Driving
Performance of Occasional and Heavy Cannabis Users but is Not Detected in Standard Field Sobriety Test, 223
PSYCHOPHARMACOLOGY 439, 444 (2012) (“[T]he overall score on SFST did not discriminate between THC and
baseline.”).
167

31
.

the One Leg Stand test was the most successful, with the baseline displaying 21% impairment
and the subjects who had taken marijuana displaying 50%. 172 For the HGN, there was 0%
baseline impairment and 15% impairment for the subjects who had taken marijuana. 173 The Walk
and Turn test was found to be the worst indicator in this study. When the Walk and Turn Test
was administered, 58% were found to be impaired and 35% of the marijuana-intoxicated subjects
were found to be impaired, meaning that sober subjects were actually more likely to be
considered intoxicated. 174 The researchers in the 2012 study finally concluded that the SFSTs
were only mildly accurate in detecting marijuana intoxication, perhaps because the heavy users
had developed tolerance to THC’s behavioral effects. 175 One thing to consider when looking at
these supposedly adverse findings is that the 2005 study was not comparing against a baseline,
but comparing impairment on SFSTs to impairment on driving tests. 176 As the Walk and Turn
test assesses individual ability to perform a divided attention task, and as driving is a divided
attention task, a reduced ability to perform on one is likely to be linked to reduced ability to
perform on the other. Though opposed in conclusion, both the 2005 and the 2012 studies expose
the serious weakness of potential false positives on SFSTs.
In a two-year study of SFST field application, researchers took cannabinoid-positive
whole blood samples that were collected from drivers and evaluated whether THC concentration
in the blood was correlated with poor performance on SFSTs. 177 Of the 363 positive whole blood
samples, 116 (55.3%) received an evaluation from a Drug Recognition Expert [hereinafter
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“DRE”] officer. 178 The range of THC ng/ml in the blood samples was between 2–60, with a
mean of 9 and a median of 6. 179 As time is an important factor in considering blood samples, the
researchers noted that for evaluations, the average time between driving and FST start was 69
minutes, the time between FST to blood draw was 123 minutes, and the total time between
contact and blood draw was 193 minutes. For non-DRE evaluations, the average time between
driving and FST was 33 minutes, FST to blood draw was 121 minutes, and the total time
between contact and blood draw was 152 minutes. 180
Of the 309 THC-positive subjects, 78.6% evaluated for HGN exhibited zero of the cues
that the HGN evaluates, which was an expected result, as studies have showed that THC does not
typically cause HGN. 181 For the Walk and Turn Test, “[t]here was no correlation of number of
cues present with the concentration of THC found in the blood.” A range of 75-100% of the
Walk and Turn Test subjects displayed 2 or more cues, regardless of the amount of THC in their
blood. 182 Given the results found in the previous studies, this may not be an indicator of the test’s
accuracy, as the researchers suggest, 183 but an indicator that it is relatively easy to fail the Walk
and Turn Test. In the One Leg Stand Test, 64.9% of the subjects displayed two or more cues,
with no correlation between number of cues seen and THC range in the blood. 184 The researchers
concluded that “not every individual suspected of being under the influence of cannabis with
THC in their blood performed poorly on every FST. This is further evidence that the FSTs,
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symptomatology, along with the presence of THC in the blood, should be used in totality to
make the opinion of impairment for the purposes of driving.” 185
There were a significant number of limitations with this field study. First, as discussed
supra Part C.i, blood THC level does not necessarily correlate directly to an individual’s level of
impairment. Therefore, using blood THC level to attempt to evaluate the efficacy of SFSTs in
judging impairment may not be accurate. Second, this study evaluated impairment as measured
by SFSTs, which does not correlate directly to impairment for the purposes of driving. Third, as
this was a field study, the conditions were so varied and were under such little control of the
researchers, that any number of variables could have interfered with and compromised the
quality of the results. However, the researchers’ conclusion need not be rejected because of these
limitations. If SFSTs are linked in some way to measuring impairment, police officers could
conceivably link evidence of poor driving ability, symptomatology, and blood or urine tests
together to prove impairment.
iv.

Marijuana Breathalyzer

In a push to develop a technology that is as easy, simple, and accurate as the Breathalyzer
for testing BAC, a private company, Hound Labs, has released the “Marijuana Breathalyzer.” 186
This technology is currently undergoing testing by police departments. 187 Information about how
these devices work, and exactly what they detect, has not been released to the public at large. On
their website and in press releases, Hound Labs has provided clues about how its new technology
works. Hound Labs states on its website that it has developed “ultra-sensitive technology for
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non-invasive breath measurement”, claiming that “[u]sers with THC in their breath are within the
impairment window” and that THC’s “presence indicates recent use and thus likely
impairment.” 188 Hound Labs also notes that the Hound Marijuana Breathalyzer is calibrated so
that it will trigger a positive test above the baseline of 5 pg/liter of breath. 189 Given that “ultrasensitivity” tends to be inconsistent with accuracy when concerning THC testing, as discussed
supra, and that THC’s presence does not always indicate either recent use or impairment, there
may be some serious issues with these conclusions. However, as the Marijuana Breathalyzer is a
relatively new technology, and breath analysis works differently then blood or urine analysis, 190
the weaknesses of other tests may not apply to it. Understanding of how breath alcohol sensors
currently work to analyze the presence of alcohol, and an analysis of prior studies using breath to
measure THC levels, may provide insight into whether or not the Marijuana Breathalyzer is an
effective method for measuring marijuana intoxication.
There are several kinds of sensors that measure alcohol in the breath. There are a variety
of different kinds of chemical sensors, using methods such as colorimetry, fluorescence, and
luminescence. There are also biosensors that use enzymes and certain microbial strains.
However, these testing methods are generally expensive, as they require the time and expertise of
lab technicians and/or chemists. Many of them also require the use of advanced equipment,
which is often heavy and/or delicate, and therefore not particularly portable. Finally, these
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methods tend to take time. For these reasons, these kinds of techniques are generally reserved for
confirmatory tests rather than initial roadside tests.
The fuel cell-based breath alcohol sensor is the most common, cheap, and portable type
of breathalyzer. The fuel cell-based breath alcohol sensor (hereinafter “Fuel Cell Breathalyzer”)
works by detecting ethanol in the breath electrochemically. 191 The Fuel Cell Breathalyzer has
two compartments with platinum-painted electrodes, a cathode and an anode, which are
separated by a proton-exchange membrane. 192 The Fuel Cell Breathalyzer also contains an
external circuit. When ethanol-infused breath is introduced into the anode compartment, it
undergoes a process known as heterogeneous electrocatalytic oxidation, in which the ethanol
travels over the platinum, the solid catalyst, and binds to the atoms on the platinum’s surface. 193
This process converts the ethanol, C2H5OH, 194 to 12 H+ + 12 e— + 2 CO2. 195 This reaction also
produces some chemical byproducts, most commonly acetic acid. 196 The protons and electrons
generated by the anode then are transported to the cathode, protons through the proton-exchange
membrane, the free electrons through the external circuit. 197 The protons and electrons then
undergo a reaction with oxygen, forming water. These ethanol oxidation reactions produce an
electrical charge. The charge is used to measure the amount of ethanol in the sample, which is
then correlated to BAC. 198 Because of the structure and workings of the Fuel Cell Breathalyzer,
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ethanol is vital to its inner workings. Therefore, the cheap, handheld Fuel Cell Breathalyzer is
not an option for detecting THC, and is unlikely to be the technology utilized by Hound Labs.
Larger, more expensive infrared spectrophotometers may also be used to test for alcohol
in the breath. Infrared spectroscopy is a technique of chemical analysis. 199 In the infrared region
of the electromagnetic spectrum, molecular vibrations occur, and certain functional groups have
particular absorption frequencies. 200 Infrared spectrophotometers pass beams of infrared light
covering a certain frequency range through an organic sample. 201 That spectrum is then obtained
as a chart which shows the absorption peaks of the sample. 202 Infrared spectroscopy can be used
as an evidential test at police stations, as it is capable of precisely measuring the amount of
ethanol that is present in exhaled breath, 203 as well as in blood, if necessary. 204 Because infrared
spectrophotometers are quite expensive, 205 as well as large, and the Fuel Cell Breathalyzers are
capable of sufficiently measuring BAC roadside, police officers are not equipped with their own
spectrophotometers.
Other methods, such as colorimetry and flurometry, are also capable of detecting THC.
Technicians currently test for cannabinoids with colorimetry206 by mixing the sample with
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certain chemicals, most commonly with the Duquenois-Levine test. 207 The Duquenois-Levine
test combines the sample with the Duquenois reagent, hydrochloric acid, 208 and chloroform. 209 If
THC is present, the solution will turn purple. 210 This is destructive to the sample, requires human
intervention and observation, and usually requires a larger sample than breath provides. Due to
its low discriminating power, it is generally used to test samples of the drugs themselves, not
bodily fluids. 211 One study used a digital fluorometer, which measures the wavelengths of
fluorescence in a sample, to detect THC, with some success. 212 It proposed that the fluorometer
test could work roadside. However, the fluorometer tested saliva, not breath, and required 30
minutes of incubation to produce a result. 213
A short demonstration of the Marijuana Breathalyzer’s testing process was given by
Hound Labs’ CEO, Mike Lynn. 214 He picked up a small plastic cartridge, stating that it was
disposable and that there was a “whole bunch of science” in it. He then slid the cartridge into the
handheld device and blew into the device for 30 seconds. The device began assessing for THC
within the 30 seconds, and had a result by the time the 30 seconds was over. 215 He then slid the
handheld device into a base station, which keeps the sample at a constant temperature, and noted
that the Marijuana Breathalyzer requires a constant temperature for consistent results. 216 As

enzymes that become colored upon exposure to reagents. See, e.g., Morgan Philp & Shanlin Fu, A Review of
Chemical “Spot” Tests: A Presumptive Illicit Drug Identification Technique, 10 DRUG TEST ANAL. 95, 96.
207
See id. at 98 (noting that the Duquenois-Levine test is used for cannabis).
208
The solution is “2.5 ml acetaldehyde and 2 g vanillin to 100 ml ethanol . . . .” Id. at 97.
209
Id.
210
Id. at 98.
211
Id. at 95.
212
Brian Plouffe & Shashi Murthy, Fluoresence-Based Lateral Flow Assays for Rapid Oral Fluid Roadside
Detection of Cannabis Use, 38 ELECTROPHORESIS 501, 505 (2016) (“[I]t was shown that a simple fluorescent‐based
assay, using polymeric nanoparticle, could viably detect recent THC use in OFs.”).
213
Id. at 501, 503.
214
Eric Westervelt, The Pot Breathalyzer is Here. Maybe, NPR (Aug. 4, 2018),
https://www.npr.org/2018/08/04/634992695/the-pot-breathalyzer-is-here-maybe.
215
Id.
216
Id.

38
.

biological field samples need to be retested at the police station to be considered confirmatory
evidence, this device is likely intended to preserve the sample for that purpose. The
demonstration rules out some possibilities as to the nature of the device, but not others. The
colorimeter is unlikely, as the reagent, hydrochloric acid, and chloroform need to be added at
different times for colorimetry to work properly. The device may be a fluorometer, as one study
did provide a proof-of-concept mechanism that can detect THC, but the amount of time that the
Marijuana Breathalyzer takes is very short, and thus is inconsistent with the 30-minute
incubation period that the previous study found was required to analyze a sample with the
fluorometer. The amount of time that the Marijuana Breathalyzer takes to scan and provide a
result, and the apparent lack of need for a reagent or solution, is consistent with an infrared
spectrophotometer. However, there does not appear to be an infrared spectrophotometer
currently on the market that is as compact as the Marijuana Breathalyzer.
Regardless of what the Marijuana Breathalyzer is, and how it works, there are definite
issues with using breath to detect THC. One issue of using breath to test for THC is the fact that,
unlike alcohol, THC and its byproducts are not excreted from the lungs in large quantites. 217
Because this area is rather poorly studied and tested compared to alcohol breath tests and THC
blood and urine tests, researchers have been unable to pinpoint exactly what is being detected
when administering a breath test. A 2016 pilot study set out to measure the THC that was
exhaled over time and compare it to physiological changes over time. 218 The researchers
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theorized that the source of THC in the breath is from THC being inhaled and partially deposited
in the fluid lining the airway. 219 This theory, if proven in practice, would mean that those who
test positive for THC on a breath test could have recently smoked marijuana, or perhaps been in
the presence of someone else who was smoking marijuana. The researchers had thirteen subjects,
all of whom had a history of cannabis use, abstain from using THC before the experiment. 220 The
subjects first breathed into a mouthpiece attached to a bag lined with a polymer filter to trap
microparticles, establishing a baseline. The subjects then smoked self-procured joints and
returned to breathe into the mouthpiece again. The specimens were analyzed using the liquid
chromatography-tandem mass spectrometry method. 221 The chronic users already had a
significant level of THC in their breath when taking the baseline test. 222 Many of the infrequent
users also had detectable THC concentrations in their breath for the baseline test, though there
was a statistically significant difference between their baseline concentrations and the baseline
concentrations of the chronic users. 223
The time frame for detecting THC in the breath above baseline after smoking was
estimated to be approximately three hours. 224 This contrasted with two previous studies, which
found windows of .5-2 hours 225 and 12m–12 hrs 226 after smoking. The THC concentrations in
the 2016 were consistently very high, at a range of 136 to 20,948 pg/filter, and a mean of 4192
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pg/filter. 227 This was again in contrast to previous studies, one finding concentrations between
18.0 and 77.3 pg/min (~180pg–770.3 pg/filter), 228 and another finding concentrations between
~50-1170 pg/pad. 229 The 2016 researchers theorized that, due to an inability to fully control the
subjects, the subjects may have smoked or handled cannabis before the test, skewing the results
higher than usual. 230 Alternatively, the subjects may have breathed in THC through secondhand
smoke in the testing room and also may have had mouth residue of THC in their mouths that
affected the samples. 231 In addition, the researchers theorized that the THC concentrations may
have been higher than expected because the potency of the THC in the joints, provided by the
subjects themselves, was not tested, presenting a major control problem. 232
Though the specific technology of the Marijuana Breathalyzer is unclear, previous
scientific testing has shown limitations in breath testing for THC. Secondhand smoke, residual
THC in chronic smokers, mouth residue, and wide potential time ranges for detection all present
problems. The biggest issue with the breath tests appears to be that they can detect trace amounts
of THC, but no scientific testing has shown that those trace amounts are connected to
impairment. The CEO of Hound Labs, Mike Lynn, himself stated that searching for the THC in
the breath is “kind of like putting together more than a dozen Olympic size swimming pools and
saying, ‘Hey, go find those 10 specific drops of water and in those 10 pools put together.’” 233 It
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is always possible for technological innovation to leap forward, and perhaps Hound Labs has
succeeded in creating an accurate technology that has gone briefly untested and undiscovered.
Absent further research, however, it is best to exercise caution in considering the results of these
kinds of tests.
D. Evaluating the Appropriate Standards for Admission of Expert Testimony in
Marijuana DUI Prosecution
i.

Overview

If the results of a scientific tests, such as the results of a blood or urine test for THC, are
offered into evidence, the analyst who performed the tests and prepared the report must testify as
an expert witness to confirm the report’s veracity. 234 The appropriate admissibility standard for
expert testimony and, therefore, expert evidence, depends upon the jurisdiction. Federal courts
follow the standard set by Rule 702 of the Federal Rules of Evidence [hereinafter “FRE”] and the
Supreme Court case of Daubert v. Merrell Dow Pharmaceuticals. 235 Under these authorities, in
the event of an objection, the judge, acting as a gatekeeper, must assess the admissibility of the
expert evidence based on whether there is a scientifically valid methodology underlying the
expert’s testimony. 236 The Daubert court provided a non-exhaustive list of “factors” that may be
used to determine if the evidence is the product of sound scientific methodology. 237 In Kumho
Tire Co. v. Carmichael, the Court held that this standard applies to all expert testimony,
including testimony from experts in non-scientific fields. 238 Since the FRE do not apply to the
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Melendez-Diaz v. Massachusetts, 557 U.S. 305, 309–11 (2009). The expert witness is not required to testify if he
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509 U.S. 579 (1993).
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Id. at 592–93.
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(1) Whether the theory or technique used can be, and has been, tested; (2) whether the theory or technique has
been subject to peer review and publication; (3) whether the rate of error is known and, if so, whether the rate of
error is acceptable; (4) whether there are standards controlling the technique’s operation; (5) whether there is general
acceptance of the technique in the scientific community. Id. at 593–95.
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526 U.S. 137, 138 (1999).
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states, individual states have the option to adopt this standard or to use their own. Many state
legislatures have adopted the language in the FRE’s Rule 702 and the Daubert standard along
with it. Some states have different phrasing in their Rules of Evidence. In addition, some courts
still use the standard set in Frye v. United States, where evidence derived through a scientific
technique is only admissible when the technique is generally accepted has been shown to be a
reliable one in the relevant scientific community. 239
There are different types of expert witnesses who may testify in marijuana DUI cases. If
the evidence includes a report or affidavit on blood or urine taken from the defendant, the
technician who performed the testing may testify about the equipment he used and the scientific
procedures he followed. 240 The technician will offer his opinions about the working condition of
the equipment and the validity of the scientific procedures followed by the laboratory. A
toxicologist, either forensic or medical, 241 may appear to educate the jury about how the
defendant’s behavior, physical symptoms, performance on sobriety tests, and test results
correlate with impairment. The toxicologist may also be the person who performed the original
tests, obviating the need for a technician to testify. A certified drug recognition expert (DRE)
may testify about the defendant’s behavior, physical symptoms, and performance on the SFSTs,
and render an opinion about whether the defendant was incapacitated based on his observations.
These expert witnesses are subject to judicial scrutiny to determine whether their testimony and
report are admissible.
The scientific evidence that is used for prosecution should be subject to constant
reevaluation. The Daubert and Frye standards are structured such that the passing of time,
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technological and other scientific progress, and the shifting of consensus in the scientific
community can make previously admissible techniques inadmissible. No test can be, or should
be, insulated from scrutiny, no matter its popularity or its history of extensive use. With the
potential widespread legalization of marijuana in the United States visible on the horizon, now
more than ever it is important to consider the usage of expert reports and expert testimony in
marijuana DUI cases. As the Marijuana Breathalyzer is a new technology, and little is known
about its operation, evaluating its admissibility under Daubert is not possible. An inability to
evaluate its scientific methodology suggests that it should not and cannot be used to prosecute
marijuana DUI cases at this time.
ii.

Cases Evaluating Admissibility of Blood and Urine Testing

Only a handful of cases discuss the accuracy of blood and/or urine analysis in proving
marijuana intoxication. Judges typically prefer to have evidence presented to the jury, allowing
jurors to weigh its reliability and the credibility of the witness, rather than preclude its admission
entirely, 242 and blood and urine tests are both common and popular. Of the handful of cases
directly addressing the issue, only a small percentage of those involve a substantive analysis of
admissibility. In State v. Sercey, 243 the state appealed a Florida trial court order granting the
defendant’s motions to exclude expert testimony from the state’s toxicologists. 244 Part of the trial
judge’s decision to exclude the testimony was based on the finding that“there is no generally
accepted per se limit for impairment of THC and [TCH-COOH] in blood” and “establishing a
link between impairment and specific amounts of THC in blood is complicated by the fact that
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See, e.g., Daubert, 509 U.S. at 596 (“Vigorous cross-examination, presentation of contrary evidence, and careful
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evidence.”).
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chronic users of marijuana would likely have a baseline level of THC in their blood at all
times.” 245 During the Frye hearing, the state argued that the absence of a generally accepted per
se limit for impairment from THC in the blood does not preclude the admission of blood tests,
as, under Florida common law, the state may prove impairment from alcohol even if the
defendant’s BAC is below the statutory limit. 246 The appellate court agreed, holding that the state
may use evidence of THC in the blood in conjunction with other evidence of impairment and that
evidence of the presence of THC in the defendant’s blood is therefore admissible, “even if it
cannot be quantitatively related to impairment . . . .” 247
Similarly to Sercey, in Logan v. Cooper Tire & Rubber Co., 248 the court held that the
state’s expert was permitted to rely on urinalysis to form an opinion on impairment through
marijuana use, even though the expert conceded “that a urinalysis alone [could not] support his
opinion of marijuana-based impairment,” 249 because the expert used the urinalysis and the
defendant’s “cumulative evidence of drug abuse” to form his opinion. 250 The implication of that
holding is that, in the absence of other evidence of drug abuse and intoxication, experts may not
rely solely on urinalysis results to testify to impairment. The court also noted that Daubert does
not hold experts to the “exacting standard” of determining the precise time of consumption or the
exact degree of impairment. 251 In the court’s opinion, because the expert “applied accepted
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Id. (internal quotation marks omitted). Much of the trial judge’s decision and the appellate court’s opinion
involved the reliability of the testing procedures used by the toxicologist that tested the defendant’s blood. Id. at 974.
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toxicological standards in interpreting the urine results in this case, his opinion is reliable and
relevant for the jury's consideration.” 252
In Wingfield v. State ex rel. Dept. of Transp. and Development, 253 the court stated that
“tests available to determine levels of marijuana in one's system and its effects on driving are far
from settled areas of science.” 254 However, the court determined that the proponent of the
evidence is not obligated under Daubert to submit evidence that has an “absolute degree of
certainty.” 255 It concluded that it is enough that “the proponent of the evidence show that the
expert's conclusion has been arrived at in a scientifically sound and methodologically reliable
fashion.” 256 Though the plaintiff argued that it is improper to infer impairment from urinalysis
alone, the court noted that the experts relied on other evidence to form an opinion on the
defendant’s impairment. 257 Namely, the state’s experts used eyewitness testimony to classify the
driver as an “occasional user” and used predictive models to determine the “detection time” of
THC/THC-COOH in the urine for occasional users. 258 The court held that the trial court judge
erred by excluding the expert testimony, concluding that the trial judge made an improper
determination on the credibility of the expert, not the admissibility of the evidence. 259
In State v. Jayne, the Oregon Court of Appeals affirmed the trial’s courts exclusion of the
results of urinalysis. 260 A laboratory report from the state’s forensics lab showed that the
defendant had marijuana metabolites, as well as the metabolites of other drugs, in her urine. 261
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Under Oregon precedent, there must be a “reasonably high correlation” between the results of
the test and the defendant’s impairment for the test to be admitted. 262 The urinalysis evidence
could only demonstrate that the defendant “had used drugs some time before the accident.” 263
The court held, therefore, that “the urinalysis evidence simply [could not] properly be viewed as
having a direct correlation to the impairment of the subject at the time of the accident.” 264 The
court referred to Daubert approvingly as part of their analysis, concluding that because of the
power and potentially misleading nature of expert testimony, courts should carefully
counterbalance its probative value and its potential prejudicial effect. 265 Because the jury could
be prejudiced by the test results and infer that the defendant was impaired at the time of the
accident or that she was a generally reckless person, the court held that the prejudice that the test
results could cause outweighed its probative value. 266 In a similar case, Indemnity Insurance v.
Petit, 267 the court ruled that the evidence of the defendant’s marijuana use was inadmissible
because the blood and urine tests done were only able to show that the defendant had used
marijuana at some point in the past. 268 The court concluded that, without corroborating evidence
of impairment at the time of the defendant’s accident, the test results could not be admitted and
the expert could not reliably make a conclusion about the defendant’s state of intoxication.269
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Id. at 544 (noting that in a different case, the Oregon court “concluded that the evidence should not be excluded
because the proponent of the evidence had adequately demonstrated, through the studies it introduced into
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When reviewing these cases, a common thread becomes clear: The results of blood and
urine tests, standing alone, are insufficient to prove impairment. The tests themselves are
typically not at issue, if the technician or toxicologist followed proper procedures in performing
them. But because of the tests’ general inability to prove intoxication, their probative value is
limited in cases where actual impairment is at issue. In the same vein, an expert cannot provide a
reliable and helpful opinion as to intoxication with only the results of blood or urine tests, as the
tests, standing alone, are not capable of proving impairment.
In the states of Florida, Kentucky, Louisiana, Oregon, and Wyoming, the states where the
above cases were decided, the state is required to prove that the defendant was under the
influence in DUI cases. 270 In contrast, as discussed in supra Part A, some states have per se
standards for THC in the blood or urine in their DUI statutes. Because of this, when prosecuting
a marijuana DUI case, the government need only prove beyond a reasonable doubt that the
defendant was driving with the requisite amount of THC in his blood or urine. In these cases, the
government may present the lab report and bring forth the technician or toxicologist to testify as
to the state of the equipment and the validity of his procedures. In these jurisdictions, challenging
the admissibility of the blood or urine tests is difficult. The problems with blood and urine
testing, discussed supra Parts C.i and C.ii, are not with finding THC or its metabolites in the
blood or urine; they are with correlating the level of THC in the blood or urine to impairment.

270

Fla. Stat. § 316.193 (stating that a person is guilty of driving under the influence if he is under the influence of
alcohol, drugs, or other controlled substances and is “affected to the extent that [his] normal faculties are impaired . .
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of safely driving . . . Is under the influence of a controlled substance . . . .”).
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The accuracy of the tests used to find the amount of THC in blood or urine is not in serious
dispute. Even if the entire scientific community reached a perfect consensus in finding that blood
and urine tests are not capable of detecting impairment from marijuana, the per se states could
continue to use the tests to secure convictions, since impairment is not actually at issue. In most
cases, the defendant’s only path for excluding the evidence would be alleging that the
technician’s procedure was improperly performed or otherwise scientifically invalid.

iii.

Cases Evaluating Admissibility of Standardized Field Sobriety Tests

The admissibility of the results of SFSTs, unlike blood and urine tests, has been
extensively challenged under Daubert and Frye. This may be because SFSTs have less indicia of
reliability than blood and urine tests. As discussed supra Part C.iii, the SFSTs have been shown
to be unreliable in detecting intoxication from marijuana, even in laboratory conditions, 271 where
distractions and other contributing factors can be limited or eliminated by the researchers. The
SFSTs are usually conducted roadside, 272 which introduces many factors that cast doubt on the
results. For example, the time of day and weather conditions can limit visibility, the environment
can be inherently distracting, or the examinee could have a physical or mental condition that the
examiner does not have the proper training to recognize or evaluate. 273 In addition, unlike blood
and urine tests, SFSTs do not have a long history of usage by law enforcement. The widespread
use of SFSTs by law enforcement is a relatively recent development, with the “SFST Battery”
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See supra Part C.iii.
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(HGN, Walk-and-Turn, and the One Leg Stand) having been developed and promulgated by the
National Highway Traffic Safety Administration in 1981. 274
The Walk-and-Turn and One Leg Stand tests have often been classified as parts of the
arresting officer’s general observations of the defendant’s conduct and appearance, 275 making the
results of such tests lay testimony, not expert testimony, and therefore not subject to evaluation
under Frye or Daubert. 276 The admissibility of HGN, on the other hand, has been more
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National Highway Traffic Safety Administration, Standardized Field Sobriety Test (SFST) Validated at BACS
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stringently questioned, as the relevance of HGN to the case depends on a scientific assertion that
HGN is linked to alcohol or drug intoxication. Some jurisdictions have accepted HGN as entirely
admissible. For example, the Court of Appeals of Georgia held that the HGN testing for alcohol
intoxication has reached a level of “verifiable certainty” in the scientific community and that a
trial court may take judicial notice of that verifiable certainty without receiving evidence. 277
Similarity, the Supreme Court of Illinois held that a properly-conducted HGN test may be
presumptively admitted under Frye to prove impairment. 278 Other courts have been less
generous, holding that HGN tests are admissible, but are not conclusive of impairment. 279 Only a
couple of cases have found HGN to be scientifically unreliable and inadmissible. 280
Occasionally, courts have found individual FSTs to be less than reliable, but such
unreliability has been dismissed as ultimately inconsequential, as additional SFSTs and other
evidence has been interpreted as “curing” any issues with the individual tests. The DRE
Classification Program, which is used by all fifty states, trains DREs to use a comprehensive 12-
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step protocol to evaluate a person’s level of intoxication. 281 The twelve-step DRE Protocol as a
whole has been found generally admissible by several courts, despite the issues that the
individual tests may have. 282 In State v. Daly, the Nebraska Supreme Court found that HGN is
“insufficient to support a conviction for DUI,” but concluded that its use in a standardized
examination by a Drug Recognition Expert is admissible, as the issue is not an whether a
singular observation by a DRE can be dispositive of the issue of intoxication, but “whether an
opinion based upon all of the relevant observations is reliable enough to be admissible.” 283 In
State v. Beck, the Oregon Court of Appeals concluded that the admissibility of the DRE officer’s

281

The standardized examination by the DRE is known as the “DRE Protocol,” which is currently used by all fifty
states. Drug Recognition Experts (DRE): History and Development, THE INTERNATIONAL DRUG EVALUATION &
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(2017).
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complete examination “does not demonstrate the general admissibility of each component of
the protocol . . . we approved the 12 step DRE [examination] as scientific evidence because its
complete administration by a competent examiner qualified for admission as scientific
evidence.” 284 Some, however, still question the Protocol’s scientific reliability, with one court
commenting that there was no evidence before it that allowed it to conclude that the use of the
protocol led to scientifically accurate results. 285
This “curing,” so to speak, is also present in cases where the DRE Protocol is not used. In
United States v. Daras, the Fourth Circuit concluded that it did not need to evaluate the scientific
reliability of HGN under Daubert, since the other field sobriety tests conducted, the results of the
breathalyzer test, and the testimony of the arresting officer were “more than adequate” to support
the defendant’s conviction for DUI. 286 In Joehnk, the California Court of Appeals stated that
HGN is “neither definitive nor able to determine intoxication alone,” but concluded that HGN is
a “useful tool when combined with other tests and observations in reaching an opinion . . . .” 287
In contrast, in a recent case, the Massachusetts Supreme Judicial Court concluded that a police
officer may testify as to a defendant’s performance on the standard SFSTs, but is not permitted
to suggest that there is any proven scientific connection between the results of the test and the
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defendant’s impairment. 288 The court held that “[a] police officer may not suggest, however, on
direct examination that an individual's performance on an FST established that the individual
was under the influence of marijuana” and that an officer may not state that the defendant
“passed” or “failed” a test. 289 The court also noted its concern that the use the word “test” by an
officer or DRE may create an improper “aura of scientific validity” around SFSTs, a result it
sought to avoid. 290
iv.

Propriety of a “Totality of the Circumstances” Admissibility Standard

As the above cases demonstrate, there is confusion and inconsistency surrounding the
admissibility of tests for marijuana intoxication, especially SFSTs. The line is blurred between
expert and lay testimony, opinion versus observation, reliable and unreliable. These cases are
also complicated by the appellate courts’ standards of review. A trial court’s ruling on
admissibility must be reviewed only for abuse of discretion, not de novo, 291 and decisions on
admissibility of evidence should only be vacated if the decision affected the defendant’s
substantial rights. 292 These standards lead to “curing,” where appellate courts will conclude that
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a test like HGN is unreliable and would be inadmissible by itself, but do not vacate the trial
court’s judgment because other pieces of evidence were admitted that supported the conclusion
that the defendant was intoxicated. This type of holding serves to make the appellate court’s
statement about HGN’s inadmissibility dictum, which can be helpful, but can also lead to
unacceptable confusion, since dictum is not binding on the appellate court or on any trial or
appellate courts below it.
Another issue with the “curing” seen above is that it can perpetuate unfairness and
insulate unscientific evidence from judicial scrutiny. This self-perpetuating nature is best
demonstrated in a set of hypothetical cases. The defendant challenges the admissibility of a urine
test. The urine test, taken by itself, would be inadmissible, but the DRE also did HGN, Walk-theLine, and One Leg Stand tests and those, together with the urine test, sufficiently prove
intoxication, so the error of the urine test’s admission was harmless. The defendant challenges
the admissibility of an HGN test. HGN, by itself, is inadmissible, but the DRE also did a urine
test and the Walk-the-Line and One Leg Stand tests, and those, altogether, sufficiently prove
intoxication, so the error of the HGN’s admission was harmless. The defendant then challenges
the admissibility of the DRE expert’s opinion on intoxication, since it is not based on reliable
science. The DRE expert’s testimony is admissible because he used a protocol that included
urine testing and HGN, two scientific tests that have been successfully used to help prove
intoxication in the past.

Criminal Standards of Certainty Being Left on the Dock?, 64 ALB. L. REV. 99, 121 (2000) (“The doctrine
of harmless error insures few reversals even when a way has not been found around the formal restrictions on use.”);
Jeffrey Schuum, Precious Little Guidance to the "Gatekeepers" Regarding Admissibility of Nonscientific Evidence:
An Analysis of Kumho Tire Co. v. Carmichael, 27 FLA. ST. U. L. REV. 865, 866 (2000) (“The applicable abuse-ofdiscretion standard, frequently bolstered by harmless error analysis, makes the trial court's reliability determination
essentially irreversible.”); Judge Donald E. Shelton, Forensic Science Evidence and Judicial Bias in Criminal
Cases, JUDGES' J., SUMMER 2010, at 18, 20 (“[E]ven though there are serious questions about the scientific validity
of many non-DNA forms of forensic science evidence, criminal court judges, at both the trial and appellate levels,
continue to admit virtually all prosecution-proffered expert testimony.”).
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While the troublesome nature of this circular system is undeniable, it is important to
distinguish between preventable error and unescapable necessity. Criminal trials are always
permeated with imperfections that are born of necessity. A defendant who is convicted of murder
stands to lose his liberty or even his life, and these kinds of trials are taken extremely seriously.
Despite how seriously the prosecution takes the trial, there will never be a perfectly fair murder
prosecution, simply because it is impossible to see inside of the mind of another person.
Evidence in a trial is always limited to the things that humans can physically perceive—blood in
a car trunk, fingerprints on a knife, the words said or written by the defendant—evidence that is
imperfect because, by its very nature, it can only imply that an event has occurred. Absent a
confession, what can the prosecution rely on but implication? For proving intoxication in a DUI
case, if the prosecution cannot rely upon tests of the defendant’s bodily fluids and or upon the
intoxicated behavior of the defendant, what can it rely on? In situations like these, the right
middle ground must be found between perfect and simply improper.
The best standard to use for evaluating the admissibility of expert testimony in marijuana
DUI cases would be a modified “totality of the circumstances” test, which would mirror the
“curing” strategy that is utilized by the courts of appeals, but with a stricter standard for
reliability and general admissibility. This test would be designed both to put an end to the
circular system of admissibility of evidence and to dull the aura of scientific validity. The court
would not make a binary “admissible” versus “not admissible” decision for each isolated piece of
evidence. Instead, the court would evaluate admissibility of the evidence in a holistic manner,
considering not only the Daubert factors, but also the potential prejudicial effect versus probative
value of the scientific evidence.
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There would be two general assumptions in applying the totality of the circumstances
test. First, the results of blood and urine tests, if standing on their own, would be per se
inadmissible as proof of intoxication, since using blood or urine tests to test for legitimate
intoxication is not generally accepted in the scientific community and the tests have an
unacceptable rate of error when they are used to test for intoxication. The prosecution may make
an argument that it is being admitted for a legitimate purpose other than proving intoxication.
Even if such a legitimate purpose exists, the judge should also weigh potential prejudice versus
potential probative value under Rule 403 of the FRE, because blood and urine tests have a solid
reputation in the United States and may be surrounded in an aura of validity. Second, the results
of the Walk-the-Line and One Leg Stand tests, the physical symptoms of marijuana intoxication,
and other similar facts would usually be considered non-scientific. They would qualify as the
observations of lay witnesses, which the jury is generally capable of evaluating with their own
experiences and understandings of intoxication.
The totality of the circumstances test, using these presumptions, would evaluate each
individual case, with the basic idea being that the more reliable evidence of intoxication there is,
the more appropriate it is to admit the cumulative evidence of intoxication. To eliminate the
circular and self-perpetuating nature of admissibility in these kinds of determinations, each piece
of evidence would be considered both individually and in context. To put it simply, not all
evidence is made alike. The fact that there is a lot of the unreliable evidence does not work to
cure the fact that the individual pieces of evidence are unreliable.
As an illustrative example, an expert intends to testify to his opinion that a person was
intoxicated, based on (1) blood tests showing a high level of THC in the blood; (2) bloodshot
eyes and slurred speech; (3) swerving or otherwise failing to follow the road correctly; and (4)
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severe performative deficiencies in all the SFSTs. Blood tests, especially blood tests showing
significant levels of active THC in the blood, are more valuable than urine tests. Evidence of
intoxicated behavior, especially behavior showing that the defendant’s intoxication affected his
driving skills, is more valuable than just HGN. The individual pieces of evidence are more
reliable and, when put all together, the science behind his opinion has been more extensively
tested by the scientific community, is better-accepted in the community, and has a lower rate of
error. His testimony may be found admissible and, because of that fact, the other evidence may
be admitted as well.
Contrast the above example with that of an expert who intends to testify that a person was
intoxicated, based simply on a blood test showing a high level of THC in the blood. Though the
blood test for THC is generally more reliable than some other tests, the blood test alone cannot
be enough to admit the expert’s opinion, since a blood test by itself is not a well-accepted
scientific method to evaluate a person’s level of intoxication. The expert’s opinion is
inadmissible. While the blood test could conceivably be admitted after a Daubert analysis, since
it cannot reliably prove intoxication and its prejudicial value would outweigh its probative value,
it should be inadmissible.
In a final illustrative example, an expert intends to testify that a person was intoxicated,
based on (1) a urine test showing THC-COOH in the urine; (2) a blood test showing a negligible
amount of THC in the blood; (3) mild cognitive deficiencies in the HGN and One Leg Stand test;
(4) rapid pulse and sweating during the traffic stop. The expert plans to use just as many facts
and pieces of evidence as the expert in the first example to prove his point. However, in the
scientific field, each of the tests is considered relatively unreliable in proving intoxication. In
addition, rapid pulse and sweating can be symptoms of marijuana intoxication, but they may also
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be symptoms of stress, and they do not show intoxication that affected the defendant’s driving
skills. The evidence both individually and cumulatively is less tested, less accepted, and has a
higher rate of error. The expert’s opinion is inadmissible. The individual tests and the facts may
or may not be found admissible—however, once again, the judge should consider prejudice
versus probative value.
Some may argue that this kind of test would be evaluating weight and credibility, rather
than admissibility, and thus should be evaluated by the jury, not the judge. However, this
“totality of the circumstances” test is not intended to, nor does it, replace the role of the jury.
Evaluating the tests and the facts both individually and in context with each other does not
change the nature of the judge’s evaluation. Like an autopsy or a psychological evaluation, the
toxicologist’s conclusion is based on an assembly of facts and tests. The admissibility of each
individual fact and test does matter, but it also matters how the expert puts the pieces together.
There are multiple ways to look at an assembly of facts and multiple ultimate conclusions that
can be reached. The diversity of approaches complicates an evaluation under Daubert, since the
scientific community paints a spectrum of “sound scientific methodology” which starts at
“totally unacceptable” and ends at “totally acceptable.” It is the judge’s job as a gatekeeper to
accurately paint that spectrum and place the expert opinion at issue in the place where it belongs.
If the judge fails to do that and simply evaluates the admissibility of each individual test that the
expert used or considered, then he has have failed to consider the whole picture. By doing so, he
would allow an expert to testify to an opinion that may be acceptable on paper, but may also be
totally unacceptable in the scientific community. Making the jury ultimately responsible for
deciding how a toxicologist must evaluate and put together test results forces them into the shoes
of the scientific community, which goes against the spirit of both Daubert and Frye.
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Others may argue that this test would place too much power in the hands of the judiciary.
On the contrary, it would simply reassert a responsibility and privilege that the Supreme Court
has already vested in judges. Another argument would be that the test is biased against the
prosecution and would prevent them from carrying out their goal of protecting the public from
intoxicated driving. While the test does place more weight on proof of actual intoxication, the
pendulum swings in both directions. A test that is unfavorable for the prosecution, such as a
blood test showing a low level of THC in the blood, would not prove to be a death knell for the
prosecution’s case if they have other pieces of evidence that are enough to support an expert’s
opinion that the defendant was intoxicated. Finally, there may be an argument that this standard
would impose great administrative burdens, cost the government more money, and slow down
already slow criminal trials. While this may be the case, no amount of administrative ease and
efficiency justifies taking away a criminal defendant’s freedom. Additionally, though it may take
time, the scientific and criminal justice communities would be able to respond to the new
standard and formulate better, more reliable ways to ascertain intoxication, perhaps meaning that
eventually, judges would not have to perform a substantial amount of evaluations under the
standard.
CONCLUSION
Scientific studies have shown, over the years, that testing for marijuana intoxication is
enormously complicated. Blood tests, urine tests, sobriety tests, and breath tests all have been
shown to have points of potential error and, therefore, potential failure. Given that scientific
testing is often seen as a silver bullet in court, even with evidence to the contrary, these potential
failures run the risk of convicting sober people of DUIs, and letting intoxicated people go free.
The simple, and easiest, solution would be to say that marijuana should not be legalized in the
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United States if the United States is incapable of testing to ensure that people do not smoke and
drive. However, this solution may not be a solution at all, as people can and will smoke and
drive, regardless of the legality of marijuana.
There is no easy, right answer to this problem. On occasions like these, where the
scientific community, the legal community, and the political parties are so divided, lines must be
drawn only where impropriety can be clearly measured. The facts show that THC can be
detected in tests long after exposure and long after impairment has ceased. Because chronic
smokers, including medical marijuana patients, may be disproportionately affected, per se tests,
and especially zero tolerance tests, are an inaccurate and inequitable way of securing DUI
convictions. Instead of being based on these per se limitations, DUI convictions should be based
on actual proof of impairment, with the scientific evidence filtered through a “totality of the
circumstances” test. For that purpose, the statements of the defendant, the physical signs of
intoxication shown, evidence of impairment on SFSTs, and results on blood and urine tests
should be evaluated individually as well as altogether. The potential weaknesses and
inaccuracies in the blood and urine tests should be fully stated, and the defendant should have the
opportunity to introduce factors to contest the validity of the scientific test, such as a history of
marijuana usage, obesity, or recent weight loss. Only the combined weight of that evidence
should be used to convict or acquit a defendant. If a person was not actually intoxicated, it is
inappropriate to convict him of driving under the influence, regardless of the amount of THC in
his body.
The rationale behind the zero tolerance THC test is simple—if you have marijuana in
your system, and you drive, you should be arrested and convicted of driving under the influence.
The per se tests are similar in rationale, but simply raise the level of unacceptability. MADD,
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and many others, focus on the fact that driving after consuming an intoxicating substance is a
choice that a person makes, and choices have consequences. Getting behind the driver’s seat
after smoking marijuana, while being fully aware that it may impair your cognition and driving
capabilities, is a moral failing, an action that many see as patently unforgivable. But the law,
though it is intended to embody certain moral and societal standards, should not be focused on
the inflammatory question of moral culpability. When making decisions, decision-makers must
focus on the facts, and how they fit into our legal system. While we might morally condemn
people who pick up their joints and their car keys, that condemnation alone does not justify the
use of inaccurate tests to ensure convictions.
Forensic science’s search for objective truth is compromised when the weaknesses in its
application are exploited. Weaknesses and inaccuracies in the blood, urine, and sobriety tests
allow people to be punished for perceived moral failings under the veil of forensic science’s
objectivity and accuracy. Even if the accused can afford expert witnesses and defense attorneys
who can attack the accuracy of these forensic tests, the judge and jury may still believe that these
tests represent total scientific truth. The tests do not have to be abandoned, but their weaknesses
must be addressed and mitigated. By abandoning per se and zero tolerance tests, and requiring
that judges evaluate the scientific legitimacy of the tests used, state legislatures can help ensure
that people convicted of DUI were actually under the influence.
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